Amedeo Smart

Free Medical Literature Service

 

Amedeo

Diabetes
  Free Subscription

Articles published in
Diabetologia
    September 2026
  1. SAPONARO C, Imbernon M, Louvet I, Deligia E, et al
    Metabolic state determines the brain and direct islet effects of liraglutide on enhanced insulin secretion.
    Diabetologia. 2026;69:2534-2553.
    >> Share

  2. AIELLO E, Grieco GE, Brunetti M, Gliozzo G, et al
    Plasma small RNA profiling reveals a three-miRNA signature associated with early beta cell dysfunction across glucose tolerance stages.
    Diabetologia. 2026;69:2620-2633.
    >> Share

    August 2026
  3. DE WIT DF, Fuhri Snethlage CM, Levels JHM, Rampanelli E, et al
    High prevalence of low faecal elastase levels in individuals with type 1 diabetes is associated with diabetes duration but not with marked alterations in food intake or clinical symptoms.
    Diabetologia. 2026 Aug 8. doi: 10.1007/s00125-026-06829.
    >> Share

  4. KIMURA T, Kidokoro K, Iwamoto Y, Iwamoto H, et al
    A GLP-1 receptor agonist enhances islet microvascular flow through nitric oxide-dependent mechanisms in a diabetic mouse model: investigation using intravital two-photon imaging.
    Diabetologia. 2026 Aug 7. doi: 10.1007/s00125-026-06825.
    >> Share

  5. QADRI SF
    Screening and diagnosis of liver disease in diabetes: a guide and evidence-based assessment.
    Diabetologia. 2026 Aug 6. doi: 10.1007/s00125-026-06816.
    >> Share

  6. FUZAK NUNZIATO M, Yan B, Schliep KC, Farland LV, et al
    Endometriosis subtypes and risk of type 2 diabetes: the Advancing Research on Cardiovascular Health and Endometriosis Study (ARCHES) retrospective cohort study.
    Diabetologia. 2026 Aug 6. doi: 10.1007/s00125-026-06828.
    >> Share

  7. FLOCKHART M, Svensson M, Ehtesham E, Ryberg M, et al
    Concurrent training is associated with enhanced post-exercise ceramide clearance and fat oxidation capacity in individuals with type 2 diabetes following lifestyle intervention.
    Diabetologia. 2026 Aug 5. doi: 10.1007/s00125-026-06820.
    >> Share

  8. JORGENSEN IL, Damm P, Andersen MK, Reim PK, et al
    Predicting future risk of type 1 and type 2 diabetes after gestational diabetes mellitus using polygenic scores: a cohort study.
    Diabetologia. 2026 Aug 4. doi: 10.1007/s00125-026-06824.
    >> Share

  9. LEJONBERG C, Czuba T, Bennet L, Coral DE, et al
    Incidence and independent risk factors for heart failure in a population-based cohort of 19,892 individuals with newly diagnosed diabetes.
    Diabetologia. 2026 Aug 3. doi: 10.1007/s00125-026-06823.
    >> Share

  10. BERGENSTAL RM, Xu Y, Dunn TC, Choudhary P, et al
    Updated glucose management indicator (GMI) better aligns with HbA(1c) than current GMI: implications for clinical practice and reporting.
    Diabetologia. 2026;69:2182-2188.
    >> Share

  11. GHOSH A, Dutta K, Bhatt SP, Ansari IA, et al
    Metabolic implications of hepatic, pancreatic and abdominal adipose tissue depots in Asian Indians across normoglycaemia, prediabetes and type 2 diabetes.
    Diabetologia. 2026 Aug 1. doi: 10.1007/s00125-026-06807.
    >> Share

  12. KAHL S, Caussy C, Cusi K
    Is MASLD an independent risk factor for micro- and macrovascular complications of diabetes? A critical reappraisal and future directions.
    Diabetologia. 2026 Aug 1. doi: 10.1007/s00125-026-06817.
    >> Share

    July 2026
  13. SOE KK, Robinson E, Oleolo M, Goonoo M, et al
    Cardiac autonomic neuropathy predicts renal decline in type 1 diabetes mellitus: a 15 year follow-up study.
    Diabetologia. 2026 Jul 29. doi: 10.1007/s00125-026-06818.
    >> Share

  14. KONSTANTARA E, Lindgreen P, Kuriakose L, Zaremba N, et al
    A narrative systematic review of definitions and diagnostic criteria for disordered eating and eating disorders in type 1 diabetes.
    Diabetologia. 2026 Jul 29. doi: 10.1007/s00125-026-06805.
    >> Share

  15. BERG J, Cherry P, Cheung K, Horava S, et al
    Understanding MASLD and diabetes through lived experience.
    Diabetologia. 2026 Jul 29. doi: 10.1007/s00125-026-06808.
    >> Share

  16. VIPLE F, Pedersen SS, Andersen TH, Raben A, et al
    Effects of time-restricted eating on markers of glucose metabolism and regulation in individuals with prediabetes or type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials.
    Diabetologia. 2026 Jul 27. doi: 10.1007/s00125-026-06792.
    >> Share

  17. MORI T, Herder C, Cardoso P, Dennis JM, et al
    Type 2 diabetes subtypes for precision medicine: methodological challenges and alternative prediction-based approaches.
    Diabetologia. 2026 Jul 25. doi: 10.1007/s00125-026-06802.
    >> Share

  18. XI Y, Thorand B, Schneider A, Wolf K, et al
    Association of long-term exposure to air pollution, built environment and air temperature with the incidence of prediabetes phenotypes, and prediabetes remission and progression to type 2 diabetes: a longitudinal study in the KORA cohort.
    Diabetologia. 2026 Jul 25. doi: 10.1007/s00125-026-06814.
    >> Share

  19. STANISZEWSKA A, Jones A, Davies L, Game F, et al
    Development of a core descriptor set for studies assessing interventions for diabetes-related foot ulceration.
    Diabetologia. 2026 Jul 25. doi: 10.1007/s00125-026-06815.
    >> Share

  20. LEFERE S, Putri RR, Danielsson P, Casswall T, et al
    pFIB scores for paediatric MASLD fibrosis are associated with risk of youth-onset type 2 diabetes in children with obesity.
    Diabetologia. 2026 Jul 22. doi: 10.1007/s00125-026-06804.
    >> Share

  21. HASHIM D, Jorgensen JA, van de Weijer T, Blondin DP, et al
    Acute mild cold exposure with shivering reduces 24 h glucose levels in individuals with type 2 diabetes but not prediabetes.
    Diabetologia. 2026 Jul 20. doi: 10.1007/s00125-026-06809.
    >> Share

  22. TAYLOR PN, Cheung WY, Lagorio Price J, Boughton C, et al
    Relationship between participant-reported outcomes, residual beta cell function and metabolic parameters in youth with newly diagnosed type 1 diabetes.
    Diabetologia. 2026 Jul 17. doi: 10.1007/s00125-026-06798.
    >> Share

  23. VERGES B, Rouland A, Bouillet B, Pais de Barros JP, et al
    Dapagliflozin does not impair LDL catabolism and induces a shift towards a closer to normal VLDL(1)/VLDL(2) catabolism in individuals with type 2 diabetes: a randomised in vivo kinetic study.
    Diabetologia. 2026 Jul 17. doi: 10.1007/s00125-026-06810.
    >> Share

  24. DUAN S, Qin N, Pi J, Huang CP, et al
    Liver-to-kidney apolipoprotein J trans-accumulation exacerbates diabetic renal injury by disrupting TFEB-mediated lipid homeostasis.
    Diabetologia. 2026 Jul 17. doi: 10.1007/s00125-026-06801.
    >> Share

  25. DE LEIJER JF, Biessels GJ, Visseren FLJ, van Sloten TT, et al
    Dementia in type 2 diabetes: risk factors, disease processes and opportunities for prevention across the lifespan.
    Diabetologia. 2026 Jul 13. doi: 10.1007/s00125-026-06795.
    >> Share

  26. HORTON WB, Anderson KC, Love KM, Jahn LA, et al
    Premeal insulin administration lowers postprandial blood glucose and increases myocardial microvascular blood flow in people with type 1 diabetes: a randomised, crossover clinical trial.
    Diabetologia. 2026 Jul 11. doi: 10.1007/s00125-026-06806.
    >> Share

  27. BEDRAT A, Truchan NA, Pant T, Jia S, et al
    Age-independent immune subtypes in type 1 diabetes exhibit distinct post-onset progression rates and immunotherapeutic responses.
    Diabetologia. 2026 Jul 11. doi: 10.1007/s00125-026-06794.
    >> Share

  28. YOON J, Jeon S, Park B
    Baseline and longitudinal joint associations of alcohol consumption and obesity with diabetes risk: evaluating multiplicative and additive interactions.
    Diabetologia. 2026 Jul 2. doi: 10.1007/s00125-026-06790.
    >> Share

  29. RASMUSSEN RS, Nielsen SW, Alstrup L, Larsson TSW, et al
    GIP contributes to postprandial regulation of splanchnic blood supply in humans with type 2 diabetes: a randomised, single-blinded, placebo-controlled, crossover study.
    Diabetologia. 2026 Jul 2. doi: 10.1007/s00125-026-06788.
    >> Share

  30. SEBASTIAN-VALLES F, Sager-La Ganga C, Enriquez AJ, Blanco SJ, et al
    Correction: Analysis of glycaemic control with a connected smart pen cap in adults with type 1 diabetes: a randomised, open-label, parallel-group trial.
    Diabetologia. 2026 Jul 2. doi: 10.1007/s00125-026-06786.
    >> Share

  31. FLINT KL, Fahey A, Longo R, Fan W, et al
    Time delays between fingerstick glucose measurements and correctional insulin administration in the hospital: do they really matter?
    Diabetologia. 2026;69:1849-1857.
    >> Share

  32. RYDEN M
    Perspectives on human adipose tissue: from cellular mechanisms to clinical complications.
    Diabetologia. 2026;69:1731-1740.
    >> Share

  33. SCHONBACHER L, Walzl AM, Stern C, Kofeler HC, et al
    Short-term modulation of human milk oligosaccharides in plasma and milk by glucose and insulin: insights into postpartum metabolic regulation.
    Diabetologia. 2026;69:2029-2043.
    >> Share

  34. GAMACHE I, Fagbemi K, Harnois-Leblanc S, Greenwood CMT, et al
    Nature vs nurture of glucose homeostasis trajectories in children from the ALSPAC study.
    Diabetologia. 2026;69:1962-1974.
    >> Share

  35. MURRAY LEECH J, Arni AM, Chundru VK, Sharp LN, et al
    Polygenic background contributes to GCK-MODY clinical presentation and glycaemic variability.
    Diabetologia. 2026;69:1951-1961.
    >> Share

  36. YU G, Tam CHT, Shi M, Hughes AE, et al
    Maternal and fetal genetic predispositions to insulin deficiency and resistance affect fetal growth through distinct pathways.
    Diabetologia. 2026;69:1935-1950.
    >> Share

    June 2026
  37. FARLAND LV, Degnan WJ 3rd, Wang S, Gaskins AJ, et al
    History of infertility, risk of type 2 diabetes and HbA(1c) levels in the Nurses' Health Study II.
    Diabetologia. 2026 Jun 30. doi: 10.1007/s00125-026-06784.
    >> Share

  38. ROTH-SCHULZE AJ, Ngui KM, Martin G, Ashwood P, et al
    Delayed maturation of the milk microbiome in women with type 1 diabetes.
    Diabetologia. 2026 Jun 30. doi: 10.1007/s00125-026-06791.
    >> Share

  39. DU J, Zeng K, Zhang F, Wang Y, et al
    Remodelling of body composition surrounding the diagnosis of type 2 diabetes in three longitudinal cohorts.
    Diabetologia. 2026 Jun 30. doi: 10.1007/s00125-026-06797.
    >> Share

  40. SAID N, Jones I, Anderson-Baucum EK, Evans-Molina C, et al
    SARS-CoV-2 and diabetes: a post-pandemic reappraisal.
    Diabetologia. 2026 Jun 27. doi: 10.1007/s00125-026-06785.
    >> Share

  41. MADDALONI E, Pezzica S, Amendolara R, Sabatini S, et al
    Metabolomic profile differs between LADA and type 1 diabetes identifying tryptophan metabolism as a pathway involved in the heterogeneity of autoimmune diabetes.
    Diabetologia. 2026 Jun 26. doi: 10.1007/s00125-026-06777.
    >> Share

  42. YILMAZ UC, Kizilay DO, Kurt OK, Balaban Berber IB, et al
    Autoantibody screening in children who are first-degree relatives of individuals with type 1 diabetes in a sibling-dominant cohort in Turkey: a multicentre study on prevalence, determinants and post-screening parent-child anxiety.
    Diabetologia. 2026 Jun 25. doi: 10.1007/s00125-026-06783.
    >> Share

  43. MATEJKO B, Cyranka K, Sudul P, Susul K, et al
    Metabolic and vascular outcomes after transition to the MiniMed 780G system in adults >/=65 years with type 1 diabetes: a randomised, single-centre study.
    Diabetologia. 2026 Jun 25. doi: 10.1007/s00125-026-06780.
    >> Share

  44. MOHAN V
    Impacting lives of people with diabetes: lessons learnt in India may be applicable to other low- and middle-income countries.
    Diabetologia. 2026 Jun 23. doi: 10.1007/s00125-026-06776.
    >> Share

  45. MCCARTHY A, Kent G, Thomas J, Martine-Edith G, et al
    Gender differences in hypoglycaemia in type 1 and insulin-treated type 2 diabetes: the Hypo-METRICS study.
    Diabetologia. 2026 Jun 20. doi: 10.1007/s00125-026-06775.
    >> Share

  46. TRIVEDI PM, Catterall T, Sutton VR, Moshovakis V, et al
    Pharmacological inhibition of perforin dampens CD8(+) T cell-mediated beta cell destruction in autoimmune diabetes in mice.
    Diabetologia. 2026 Jun 11. doi: 10.1007/s00125-026-06773.
    >> Share

  47. FU Y, Long N, Sourn P, Zhang M, et al
    Gardnerella enrichment in the vaginal microbiome of women with gestational diabetes mellitus is associated with lower fetal birthweight percentiles.
    Diabetologia. 2026 Jun 11. doi: 10.1007/s00125-026-06770.
    >> Share

  48. COHENSHTAM O, Zung A, Yu A, King H, et al
    Fetal growth is driven by a bimodal fetal beta cell response and reshaped by a ketogenic diet in a mouse model of maternal diabetes.
    Diabetologia. 2026 Jun 9. doi: 10.1007/s00125-026-06771.
    >> Share

  49. MELIN A, Lespagnol E, Combes A, Berthoin S, et al
    The protective effect of high-intensity interval exercise compared with continuous moderate exercise on glycaemic decline is more pronounced in the postabsorptive vs postprandial state in adults with type 1 diabetes: a randomised crossover trial.
    Diabetologia. 2026 Jun 9. doi: 10.1007/s00125-026-06760.
    >> Share

  50. CHO A, Nostro MC
    Unravelling the developmental origins of cystic fibrosis-related diabetes.
    Diabetologia. 2026 Jun 9. doi: 10.1007/s00125-026-06768.
    >> Share

  51. BILSON J, Yaghootkar H
    Genetics of MASLD: a diabetes perspective.
    Diabetologia. 2026 Jun 8. doi: 10.1007/s00125-026-06759.
    >> Share

  52. LI H, Morris L, Bygdell M, Santosa A, et al
    SARS-CoV-2 infection and COVID-19 vaccination and the risk for new-onset type 1 diabetes: a register-based population study in Sweden.
    Diabetologia. 2026 Jun 6. doi: 10.1007/s00125-026-06767.
    >> Share

  53. PARR EB, Charrouf R, Hutchison AT, Flint SA, et al
    Time-restricted eating versus dietetic guidance on glycaemic outcomes in adults at risk of type 2 diabetes: a non-inferiority randomised clinical trial.
    Diabetologia. 2026 Jun 6. doi: 10.1007/s00125-026-06762.
    >> Share

  54. ZHANG X, Yang A, Wu H, Lau ESH, et al
    Early glycaemic exposure and cancer risk in people with newly diagnosed type 2 diabetes.
    Diabetologia. 2026 Jun 5. doi: 10.1007/s00125-026-06758.
    >> Share

  55. HU R, Hamilton N, Wang Y, Tong X, et al
    Diabetes-associated MYT1 and ST18 genes regulate human beta cell insulin secretion and survival via other diabetes risk genes.
    Diabetologia. 2026 Jun 5. doi: 10.1007/s00125-026-06757.
    >> Share

  56. STENER-VICTORIN E, Carlsson S, Hagstrom H, Taebnia N, et al
    MASLD, diabetes and PMOS across the female life stages.
    Diabetologia. 2026 Jun 5. doi: 10.1007/s00125-026-06761.
    >> Share

  57. LAVER TW, Sriram A, Wakeling MN, Siklar Z, et al
    Systematic analysis of loss-of-function variants across MODY genes demonstrates gene-specific effects and expands the spectrum of INS variants causing MODY.
    Diabetologia. 2026;69:1569-1580.
    >> Share

  58. ABDELMOEZ AM, Jollet M, Yu X, Rizo-Roca D, et al
    Thromboxane signalling links immune activation to enhanced glucose uptake in skeletal muscle.
    Diabetologia. 2026;69:1643-1658.
    >> Share

  59. MUSTAFAJEV IF, Hendriksz MS, Stienstra R, Tack CJ, et al
    Adrenaline is a prominent driver of inflammatory responses following hypoglycaemia.
    Diabetologia. 2026;69:1675-1685.
    >> Share

    May 2026
  60. BULK J, Casanueva Reimon L, Steculorum SM
    Olfactory dysfunction in obesity and type 2 diabetes: mechanistic insights from preclinical models.
    Diabetologia. 2026 May 30. doi: 10.1007/s00125-026-06755.
    >> Share

  61. PILLAY D, Paul N, Harrison A, Zaremba N, et al
    Clinical and psychological phenotypes of type 1 diabetes and disordered eating derived from a case vignette series: T1DE phenotypes.
    Diabetologia. 2026 May 26. doi: 10.1007/s00125-026-06756.
    >> Share

  62. CHEPULIS L, Gan H, Simmons D, Rodrigues M, et al
    Correction: SGLT2 inhibitor use and disparities in all-cause mortality in type 2 diabetes: insights from a multi-ethnic population.
    Diabetologia. 2026 May 22. doi: 10.1007/s00125-026-06752.
    >> Share

  63. SAJJADI SF, Sacre JW, Kowlessur S, Soderberg S, et al
    Age-related patterns of cardiometabolic risk factors for complications in type 2 diabetes.
    Diabetologia. 2026 May 22. doi: 10.1007/s00125-026-06753.
    >> Share

  64. ABITBOL A, Riddell MC, Peers S, Simonson E, et al
    Effect of somatostatin receptor 2 antagonism on glucagon counterregulation during a hyperinsulinaemic euglycaemic-hypoglycaemic glucose clamp in adult men and women with long-standing type 1 diabetes: a randomised crossover phase 1 study.
    Diabetologia. 2026 May 21. doi: 10.1007/s00125-026-06748.
    >> Share

  65. DEGROOTE L, Chrzanowski J, Lemaitre P, Wouters A, et al
    GLP1-E2 therapy delays autoimmune diabetes in late-stage prediabetic NOD mice and potentiates low-dose anti-CD3 therapy for enhanced disease protection.
    Diabetologia. 2026 May 18. doi: 10.1007/s00125-026-06750.
    >> Share

  66. BRACCO PA, Schmidt MI, de Paula D, Feter JS, et al
    Staging intermediate hyperglycaemia for type 2 diabetes prevention: the ELSA-Brasil study.
    Diabetologia. 2026 May 12. doi: 10.1007/s00125-026-06743.
    >> Share

  67. DING Y, Liu H, Jiang L, Yang Q, et al
    Integrating immune-cell transcriptomic data with Mendelian randomisation reveals novel causal genes for type 2 diabetes and its complications.
    Diabetologia. 2026 May 12. doi: 10.1007/s00125-026-06747.
    >> Share

  68. DE KAM SS, van der Velde JHPM, Veelen A, Jorgensen JA, et al
    Nocturnal fat oxidation is lower in older individuals with overweight/obesity, including those with type 2 diabetes, and is associated with fasting triglyceride levels.
    Diabetologia. 2026 May 12. doi: 10.1007/s00125-026-06736.
    >> Share

  69. LU JC, Meyer-Olesen CL, Halim B, Vogrin S, et al
    The impact of automated insulin delivery on glucose management in people with diabetes and advanced chronic kidney disease.
    Diabetologia. 2026 May 11. doi: 10.1007/s00125-026-06732.
    >> Share

  70. ERDEM N, Arribas-Layton D, Zook HN, O'Meally D, et al
    Human pancreatic ductal cells from non-diabetic donors function as non-professional antigen-presenting cells upon inflammatory cytokine exposure.
    Diabetologia. 2026 May 7. doi: 10.1007/s00125-026-06746.
    >> Share

  71. KANG S, Maya N, Morillo M, Outar M, et al
    Deep learning-powered quantification of endocrine cells and CD3(+) T cells in the natural history of type 1 diabetes.
    Diabetologia. 2026 May 7. doi: 10.1007/s00125-026-06742.
    >> Share

  72. O'REILLY L, Thai LM, Sue N, Dhenni R, et al
    Acute and resolving inflammation differentially regulates beta cell function in mice via interactions between peritoneal and islet-associated macrophages.
    Diabetologia. 2026;69:1249-1264.
    >> Share

  73. CHEN SY, Lekka C, Lemvig J, Yi X, et al
    From pancreas and islet resources to diabetes insights.
    Diabetologia. 2026 May 1. doi: 10.1007/s00125-026-06731.
    >> Share

  74. QUINN LM, Stanley D, Milano F, Perego G, et al
    Psychosocial implications, acceptability and ethics of screening for paediatric type 1 diabetes: a systematic review and mixed methods evidence synthesis.
    Diabetologia. 2026 May 1. doi: 10.1007/s00125-026-06717.
    >> Share

    April 2026
  75. WANG Y, Isasi CR, Stuebe AM, Louis-Jacques AF, et al
    Gestational diabetes and risk of type 2 diabetes: exploring the role of the gut microbiome in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
    Diabetologia. 2026 Apr 30. doi: 10.1007/s00125-026-06727.
    >> Share

  76. CHEPULIS L, Gan H, Simmons D, Rodrigues M, et al
    SGLT2 inhibitor use and disparities in all-cause mortality in type 2 diabetes: insights from a multi-ethnic population.
    Diabetologia. 2026 Apr 27. doi: 10.1007/s00125-026-06733.
    >> Share

  77. MAHAJAN N, Luo Q, Lukkes J, Abhyankar SD, et al
    Bmal1 overexpression in suprachiasmatic nucleus protects from retinal neurovascular deficits in a mouse model of diabetes.
    Diabetologia. 2026 Apr 24. doi: 10.1007/s00125-026-06734.
    >> Share

  78. BABIR FJ, Marcotte-Chenard A, Sandilands RE, D'Amico A, et al
    Exercise snacks performed in real-world settings reduce postprandial hyperglycaemia and glycaemic variability in individuals living with type 2 diabetes: a randomised crossover study.
    Diabetologia. 2026 Apr 24. doi: 10.1007/s00125-026-06741.
    >> Share

  79. MEEKS KAC, van der Linden EL, Bentley AR, Doumatey AP, et al
    Causal relationship between epigenetic markers and type 2 diabetes in West African populations: a Mendelian randomisation analysis.
    Diabetologia. 2026 Apr 24. doi: 10.1007/s00125-026-06716.
    >> Share

  80. SHAMSUTDINOVA D, Stahl D, Das-Munshi J
    Inequalities in type 2 diabetes incidence in a multiethnic population: a cohort study investigating the impact of ethnicity, migration and mental health comorbidities.
    Diabetologia. 2026 Apr 22. doi: 10.1007/s00125-026-06740.
    >> Share

  81. MEHTA K, Morton JI, Chen L, Anstey KJ, et al
    Age- and sex-specific trends in dementia mortality among people with and without diabetes: a multi-country population-based analysis.
    Diabetologia. 2026 Apr 21. doi: 10.1007/s00125-026-06725.
    >> Share

  82. SYED F, Krishnan P, Chang G, Rana J, et al
    Beta cell microRNAs function as molecular hubs of type 1 diabetes pathogenesis and as biomarkers of diabetes risk.
    Diabetologia. 2026 Apr 21. doi: 10.1007/s00125-026-06720.
    >> Share

  83. BLENCOWE M, Saleem Z, Liu R, Wang M, et al
    Multi-tissue multi-omics integration reveals tissue-specific pathways, gene networks and drug candidates for type 1 diabetes.
    Diabetologia. 2026 Apr 15. doi: 10.1007/s00125-026-06721.
    >> Share

  84. BALDWIN FD, Bedair KF, Jorgensen AL, Green L, et al
    Identification of a genetic risk factor for metformin-induced vitamin B(12) deficiency.
    Diabetologia. 2026;69:953-965.
    >> Share

  85. YAJNIK CS, Bandyopadhyay S, Bhat DS, Wagh RSH, et al
    Gestational glycaemia reflects lifelong glycaemia: the Pune Maternal Nutrition Study.
    Diabetologia. 2026;69:930-941.
    >> Share

  86. POWE CE, White F, Allard C, Shook L, et al
    Placental expression of GKN1 and diminished pancreatic beta cell function during pregnancy.
    Diabetologia. 2026;69:1060-1066.
    >> Share

  87. OZDEDE M, Pavlou P, Krasniqi V, Athanasiadou KI, et al
    The impact of blood pressure variability and African Caribbean ethnicity on the progression of diabetic kidney disease in type 1 diabetes.
    Diabetologia. 2026 Apr 1. doi: 10.1007/s00125-026-06715.
    >> Share

    March 2026
  88. SPIES R, Ufer G, Sabia R, Hummel J, et al
    Post-OGTT hypoglycaemia in newly diagnosed type 2 diabetes: frequency, characteristics and cluster assignment.
    Diabetologia. 2026 Mar 27. doi: 10.1007/s00125-026-06719.
    >> Share

  89. KIM JY, Kim S, Kim JH
    Continuous glucose monitoring and risks of acute and chronic diabetes-related complications and mortality in adults with type 1 diabetes: a nationwide cohort study.
    Diabetologia. 2026 Mar 21. doi: 10.1007/s00125-026-06709.
    >> Share

  90. MOLLER PM, Kjobsted R, Petersen MH, de Almeida ME, et al
    Correction: Effect of acute exercise and exercise training on the ability of insulin to clear branched?chain amino acids from plasma in obesity and type 2 diabetes.
    Diabetologia. 2026 Mar 19. doi: 10.1007/s00125-026-06690.
    >> Share

  91. ZHU D, Ma J, Wang W, Shi B, et al
    Correction: Efficacy and safety of efsubaglutide alfa in individuals with type 2 diabetes (SUPER1): a randomised, double-blind, placebo-controlled, Phase IIb/III trial.
    Diabetologia. 2026 Mar 19. doi: 10.1007/s00125-026-06711.
    >> Share

  92. PENG R, Liu L, Chu X, Xia Z, et al
    Plasma metabolite association profiles for type 2 diabetes genetic clusters in Finnish men.
    Diabetologia. 2026 Mar 18. doi: 10.1007/s00125-026-06710.
    >> Share

  93. DU Y, Zhang M, Li AQY, Lau ESH, et al
    Differential healthcare costs in individuals with type 2 diabetes and incident chronic kidney disease in Hong Kong: a latent class trajectory analysis.
    Diabetologia. 2026 Mar 18. doi: 10.1007/s00125-026-06698.
    >> Share

  94. MCCLURE RD, Carr ALJ, Boule NG, Yardley JE, et al
    The glycaemic response to morning fasted resistance exercise is more consistent than the response to afternoon fed resistance exercise for adults with type 1 diabetes: a randomised crossover comparison.
    Diabetologia. 2026 Mar 14. doi: 10.1007/s00125-026-06713.
    >> Share

  95. BRUTTOMESSO D, Petrie JR, Evans M, Fleming GA, et al
    Challenges in and opportunities for individualising diabetes technology: a position statement by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group.
    Diabetologia. 2026 Mar 12. doi: 10.1007/s00125-025-06651.
    >> Share

  96. CHIRIACO M, Trico D, Giannoni A, Sacchetta L, et al
    Impact of canagliflozin on the cardiorenal effects of dietary sodium intake in type 2 diabetes: a post hoc analysis of the CREDENCE trial.
    Diabetologia. 2026 Mar 12. doi: 10.1007/s00125-026-06705.
    >> Share

  97. CAO J, Liu F, Kong H, Lai C, et al
    Integrated intraocular-plasma proteomics reveals conserved biomarkers for diabetic retinopathy progression: a multi-fluid biopsy study.
    Diabetologia. 2026 Mar 12. doi: 10.1007/s00125-026-06708.
    >> Share

  98. EVANS-MOLINA C, Gitelman SE, Mari A, Ferrannini E, et al
    Beta cell glucose sensitivity identifies clinical response to disease-modifying therapies initiated at stage 3 type 1 diabetes onset.
    Diabetologia. 2026 Mar 12. doi: 10.1007/s00125-026-06703.
    >> Share

  99. CARR ALJ, Sutton H, Agesen RM, Bonifacio E, et al
    Continuous glucose monitoring as a tool in early-stage type 1 diabetes.
    Diabetologia. 2026 Mar 9. doi: 10.1007/s00125-026-06707.
    >> Share

  100. CUNNINGHAM HA, Ward L, Butler MP, Valent AM, et al
    Early meal timing improves nocturnal glucose in pregnancies complicated by gestational diabetes.
    Diabetologia. 2026 Mar 9. doi: 10.1007/s00125-026-06701.
    >> Share

  101. DE ALMEIDA ME, Ortenblad N, Platz AB, Petersen MH, et al
    Mitochondrial cristae density is increased following high-intensity interval training in men with type 2 diabetes.
    Diabetologia. 2026 Mar 8. doi: 10.1007/s00125-026-06694.
    >> Share

  102. HUMBERT A, Nawrot M, Bendridi N, Gouriou Y, et al
    Endoplasmic reticulum-mitochondria contact sites are signalling hubs connecting nutrient sensing and GLP-1 secretion in L cells of the mouse gut: from physiology to obesity and type 2 diabetes.
    Diabetologia. 2026 Mar 8. doi: 10.1007/s00125-026-06693.
    >> Share

  103. JUMENTIER B, Qu HQ, Lu T, Liu K, et al
    Development and validation of a trans-ancestry polygenic risk score for type 1 diabetes.
    Diabetologia. 2026 Mar 7. doi: 10.1007/s00125-026-06706.
    >> Share

  104. PHUAH P, Norton M, Cheng S, Roberts AG, et al
    The microbial tryptophan metabolite indole acts on the gastrointestinal tract to improve glucose homeostasis in a mouse model of diabetes by enhancing GLP-1 secretion and L cell differentiation.
    Diabetologia. 2026 Mar 4. doi: 10.1007/s00125-026-06688.
    >> Share

  105. MA G, Wu W, Duan Y, Yang Y, et al
    A diabetes-induced change of MDM2 SNP309T-->G contributes to aberrant retinal angiogenesis.
    Diabetologia. 2026 Mar 2. doi: 10.1007/s00125-026-06695.
    G contributes to aberrant retinal angiogenesis.&body=MA G, Wu W, Duan Y, Yang Y, et al. A diabetes-induced change of MDM2 SNP309T-->G contributes to aberrant retinal angiogenesis. Diabetologia. 2026 Mar 2. doi: 10.1007/s00125-026-06695. https://pubmed.ncbi.nlm.nih.gov/41770245" ALT="Email" TITLE="Email"> --> >> Share

  106. KATTE JC, Bavuma C, Wild SH, Hawkins M, et al
    Atypical diabetes subtypes in Black African populations.
    Diabetologia. 2026 Mar 2. doi: 10.1007/s00125-026-06697.
    >> Share

  107. DANGARDT F, Forsander G, Bergdahl E
    Beyond BMI: the need for improved adiposity assessment in studying subclinical cardiovascular autonomic neuropathy in children with type 1 diabetes. Reply to Risi R, Buzzetti R, Maddaloni E [letter].
    Diabetologia. 2026 Mar 2. doi: 10.1007/s00125-026-06699.
    >> Share

  108. COUPER JJ, Oakey H, Penno MAS, Wentworth JM, et al
    Evolution of islet autoantibodies in the Environmental Determinants of Islet Autoimmunity (ENDIA) prospective cohort.
    Diabetologia. 2026;69:631-642.
    >> Share

  109. JIANG Y, Wu D, Ni Y, Liu Y, et al
    Peptide hormone spexin restores beta cell function and improves glycaemic control in mice via regulation of the sodium-potassium pump.
    Diabetologia. 2026;69:710-726.
    >> Share

    February 2026
  110. RISI R, Buzzetti R, Maddaloni E
    Beyond BMI: the need for improved adiposity assessment in studying subclinical cardiovascular autonomic neuropathy in children with type 1 diabetes.
    Diabetologia. 2026 Feb 27. doi: 10.1007/s00125-026-06700.
    >> Share

  111. RUSSON CL, Allen MJ, Cockcroft E, Pemberton JS, et al
    GlucoseGo: a simple tool to predict hypoglycaemia during exercise in type 1 diabetes.
    Diabetologia. 2026 Feb 25. doi: 10.1007/s00125-026-06692.
    >> Share

  112. DOBSON JR, Dadi PK, Dickerson MT, Nakhe AY, et al
    The diabetes-associated K(+) channel TALK-2 controls human beta cell endoplasmic reticulum Ca(2+) handling, which promotes basal insulin release and limits glucose-stimulated insulin secretion.
    Diabetologia. 2026 Feb 25. doi: 10.1007/s00125-026-06683.
    >> Share

  113. YAN H, Liu J, Zhang Z, Chen S, et al
    Canagliflozin attenuates CMR-quantified myocardial fibrosis in individuals with type 2 diabetes mellitus at high cardiovascular risk: a randomised open-label controlled trial.
    Diabetologia. 2026 Feb 24. doi: 10.1007/s00125-026-06682.
    >> Share

  114. FUENTES G, Valero P, Cornejo M, Silva K, et al
    Maternal pre-pregnancy BMI differentially regulates intracellular pH in human umbilical vein endothelium from gestational diabetes mellitus pregnancies, with alkalinisation-associated reduction of adenosine transport in normal weight pregnancies.
    Diabetologia. 2026 Feb 24. doi: 10.1007/s00125-026-06679.
    >> Share

  115. LI Z, Liu S, Ho JC, Narayan KMV, et al
    Subtypes of newly diagnosed type 2 diabetes and risk of complications: analysis of electronic health records in the USA.
    Diabetologia. 2026 Feb 21. doi: 10.1007/s00125-026-06687.
    >> Share

  116. MALTESE G, Karalliedde J, Dhesi J, Bellary S, et al
    Type 1 diabetes, ageing and frailty: an underexplored intersection.
    Diabetologia. 2026 Feb 17. doi: 10.1007/s00125-026-06681.
    >> Share

  117. LUDVIGSSON J
    The rise and fall of a paradigm and conceiving a new hypothesis for type 1 diabetes. Reply to Nerup J, Lernmark A [letter].
    Diabetologia. 2026 Feb 17. doi: 10.1007/s00125-026-06689.
    >> Share

  118. SEBRAOUI S, Englund O, Nyberg F, Carlsson A, et al
    Geospatial clustering of type 1 diabetes in Sweden: a cohort study based on all residential locations from birth to diagnosis.
    Diabetologia. 2026 Feb 16. doi: 10.1007/s00125-026-06675.
    >> Share

  119. BRUNASSO A, Lange NF, Poli S, Schiavon M, et al
    Novel deuterium metabolic imaging technique reveals distinct patterns of postprandial hepatic glucose homeostasis in individuals with type 1 diabetes and healthy control individuals: a case-control study.
    Diabetologia. 2026 Feb 13. doi: 10.1007/s00125-026-06677.
    >> Share

  120. ZIVKOVIC J, Mitter M, Theodorou D, Moser O, et al
    Exercise in type 1 diabetes: real-world data on glucose levels and hypoglycaemia risk from over 420,000 exercise sessions.
    Diabetologia. 2026 Feb 13. doi: 10.1007/s00125-026-06672.
    >> Share

  121. MARZINOTTO I, Bazzigaluppi E, Brigatti C, Martinenghi S, et al
    Feasibility and performance of minimal-volume capillary blood screening for type 1 diabetes and coeliac disease autoantibodies across all age groups: the UNISCREEN population study.
    Diabetologia. 2026 Feb 10. doi: 10.1007/s00125-026-06680.
    >> Share

  122. KATTNER N, Bashir A, Shaw JAM
    The emerging role of pancreatic exocrine fibrosis as a common aetiological driver of islet dysfunction and diabetes: opportunities for novel disease-modifying interventions.
    Diabetologia. 2026 Feb 10. doi: 10.1007/s00125-026-06678.
    >> Share

  123. BORBJERG MK, Mokhtar S, Sutedja N, Koster A, et al
    Association of corneal nerve parameters with nerve abnormalities and neuropathic pain in prediabetes and type 2 diabetes: the Maastricht Study.
    Diabetologia. 2026 Feb 10. doi: 10.1007/s00125-026-06676.
    >> Share

  124. LAMPOUSI AM, Zeng J, Lofvenborg JE, Carlsson S, et al
    Red meat intake during pregnancy and childhood and risk of type 1 diabetes: findings from the ABIS birth cohort.
    Diabetologia. 2026 Feb 7. doi: 10.1007/s00125-026-06671.
    >> Share

  125. TRINK J, Gao B, Li R, Patel JH, et al
    LASP1 mediates ADAM17 upregulation in high glucose to promote fibrosis in diabetic kidneys.
    Diabetologia. 2026 Feb 6. doi: 10.1007/s00125-025-06662.
    >> Share

  126. SEBASTIAN-VALLES F, Sager-La Ganga C, Justel Enriquez A, Jimenez Blanco S, et al
    Analysis of glycaemic control and treatment satisfaction with a connected smart pen cap in adults with type 1 diabetes: a randomised, open-label, parallel-group trial.
    Diabetologia. 2026 Feb 3. doi: 10.1007/s00125-026-06674.
    >> Share

  127. BLACK SKP, Tully A, Davis EA, Roberts A, et al
    Co-designing a new clinical pathway to support families with children identified as having early-stage type 1 diabetes in Western Australia.
    Diabetologia. 2026 Feb 3. doi: 10.1007/s00125-026-06668.
    >> Share

  128. NAIR AK, Barkho K, Cheranda KP, Traurig M, et al
    Modelling the effects of human SUR1 R1420H variation on insulin secretory function using isogenic iPSC-derived pancreatic islets.
    Diabetologia. 2026;69:399-420.
    >> Share

  129. PREFONTAINE C, Pipella J, Rampazzo Morelli N, Chen YC, et al
    Insulin production is sustained during DNA damage-mediated senescence in adult human beta cells.
    Diabetologia. 2026;69:421-435.
    >> Share

  130. SMEDEGAARD S, Rittig N, Ovesen PG, Suder LB, et al
    Once-daily supplementation with pre-meal whey protein lowers breakfast postprandial glucose levels in women with GDM throughout the third trimester: a randomised, controlled, clinical trial.
    Diabetologia. 2026;69:350-363.
    >> Share

  131. THOMSON RL, Martin G, McGorm KJ, Spelman T, et al
    Perceived stress in mothers of children with and without islet and coeliac autoimmunity in the ENDIA study.
    Diabetologia. 2026;69:343-349.
    >> Share

    January 2026
  132. SIMO R, Hernandez C, Frontoni S, Sbraccia P, et al
    Relationship between retinal neurodysfunction and cognitive impairment in type 2 diabetes: results of the RECOGNISED cross-sectional study.
    Diabetologia. 2026 Jan 29. doi: 10.1007/s00125-025-06664.
    >> Share

  133. GIUDICELLI G, Krause N, Turin-Huet V, Robert M, et al
    Type 2 diabetes remission and metabolic outcomes 5 years after Roux-en-Y gastric bypass in young vs older adults: a multicentre matched cohort study.
    Diabetologia. 2026 Jan 29. doi: 10.1007/s00125-025-06665.
    >> Share

  134. BENTZEN JMM, Brask-Thomsen PK, Krogsbaek M, Hu X, et al
    Dermal fibroblast mitochondrial profiles in painful diabetic neuropathy.
    Diabetologia. 2026 Jan 26. doi: 10.1007/s00125-025-06660.
    >> Share

  135. SHARPE H, Lam GY
    The evolving understanding of cystic fibrosis-related diabetes in the highly effective modulator therapy era: a scoping review.
    Diabetologia. 2026 Jan 26. doi: 10.1007/s00125-025-06653.
    >> Share

  136. GITELMAN SE, Simmons K, Sherr JL, Quattrin T, et al
    Type 1 diabetes screening: reframing the debate from paternalism to partnership. Reply to Scaramuzza AE, Iafusco D, Cherubini V [letter] Type 1 diabetes screening: building a clinician-patient partnership for early care of chronic beta cell failure. R
    Diabetologia. 2026 Jan 24. doi: 10.1007/s00125-026-06673.
    >> Share

  137. TSAMERET S, Froy O, Matz Y, Landau Z, et al
    Glycaemic, appetite and circadian benefits of a dairy-enriched diet with high-protein breakfast and early daytime-restricted carbohydrate intake in type 2 diabetes: a randomised crossover trial.
    Diabetologia. 2026 Jan 23. doi: 10.1007/s00125-025-06658.
    >> Share

  138. MALLONE R, Bandini A
    Type 1 diabetes screening: building a clinician-patient partnership for early care of chronic beta cell failure.
    Diabetologia. 2026 Jan 23. doi: 10.1007/s00125-025-06656.
    >> Share

  139. SCARAMUZZA AE, Iafusco D, Cherubini V
    Type 1 diabetes screening: reframing the debate from paternalism to partnership.
    Diabetologia. 2026 Jan 23. doi: 10.1007/s00125-025-06654.
    >> Share

  140. LEHMANN G, Ehrmann D, Olesen B, Priesterroth LS, et al
    Uncovering distinct predictors of diabetes distress and depressive symptoms in a longitudinal survival analysis of incidence and remission: indication for diverging aetiological paths.
    Diabetologia. 2026 Jan 22. doi: 10.1007/s00125-026-06666.
    >> Share

  141. SYREENI A, Dahlstrom EH, Smyth LJ, Hill C, et al
    Blood DNA methylation markers are associated with diabetic kidney disease progression in type 1 diabetes.
    Diabetologia. 2026 Jan 22. doi: 10.1007/s00125-025-06661.
    >> Share

  142. TOKGOZ S, Deden LN, Hofboer A, Meijer RI, et al
    Beta cell function and mass in individuals with and without remission of type 2 diabetes after Roux-en-Y gastric bypass.
    Diabetologia. 2026 Jan 20. doi: 10.1007/s00125-025-06659.
    >> Share

  143. LAL R, Braune K, Lewis DM, Petruzelkova L, et al
    Fully closed-loop systems: can people with type 1 diabetes just do it? Insights from open-source systems.
    Diabetologia. 2026 Jan 19. doi: 10.1007/s00125-025-06644.
    >> Share

  144. OZ OK, Sherwood AM, Crisologo PA, Killeen AL, et al
    Prospective comparison of WBC SPECT/CT and conventional MRI for diagnosing osteomyelitis and monitoring treatment response in diabetic foot infections.
    Diabetologia. 2026 Jan 18. doi: 10.1007/s00125-025-06652.
    >> Share

  145. KARAKUS KE, Chesshir L, Walker S, Baschal EE, et al
    Teplizumab treatment for stage 2 type 1 diabetes: a real-world evaluation of metabolic and immunological outcomes.
    Diabetologia. 2026 Jan 15. doi: 10.1007/s00125-025-06646.
    >> Share

  146. VERHOOG NJD, Africander D, Storbeck KH
    Sex steroids, SHBG and type 2 diabetes in women: what do we really know?
    Diabetologia. 2026 Jan 15. doi: 10.1007/s00125-025-06647.
    >> Share

  147. WESTHOLM E, Karagiannopoulos A, Nielsen BU, Shaw JAM, et al
    Dynamic changes in circulating microRNAs during oral glucose tolerance testing support their potential as diagnostic and monitoring biomarkers in cystic fibrosis-related diabetes.
    Diabetologia. 2026 Jan 7. doi: 10.1007/s00125-025-06645.
    >> Share

  148. JOING I, Marais G, Huchez A, Lespagnol E, et al
    How adolescents with type 1 diabetes experience physical education in middle school: a qualitative study.
    Diabetologia. 2026 Jan 7. doi: 10.1007/s00125-025-06648.
    >> Share

  149. SINKE L, Delerue T, Wilson R, Lu X, et al
    DNA methylation of genes involved in lipid metabolism drives adiponectin levels and metabolic disease.
    Diabetologia. 2026;69:127-145.
    >> Share

    December 2025
  150. YUN Y, Liu YD, Yang ZM, Wang YQ, et al
    Duodenal myoelectrical hyperactivity drives diabetic remission in rat models of type 2 diabetes.
    Diabetologia. 2025 Dec 26. doi: 10.1007/s00125-025-06642.
    >> Share

  151. BERTUOL VC JR, Iorra F, Vieceli T, Tonolli NT, et al
    Effects of insulin regimens for type 2 diabetes mellitus: a systematic review and network meta-analysis.
    Diabetologia. 2025 Dec 24. doi: 10.1007/s00125-025-06633.
    >> Share

  152. DENROCHE HC, Ng V, Velghe J, Suen I, et al
    Islet amyloid disrupts MHC class II antigen presentation and delays autoimmune diabetes in NOD mice.
    Diabetologia. 2025 Dec 22. doi: 10.1007/s00125-025-06622.
    >> Share

  153. DEWHURST-TRIGG RE, Atkins J, Morgan NG, Eichmann M, et al
    Characterisation of human pancreatic mesenchymal stromal cells in type 1 diabetes.
    Diabetologia. 2025 Dec 21. doi: 10.1007/s00125-025-06634.
    >> Share

  154. CLAUSSEN C, Papadimos E, Magliano DJ, Hotu C, et al
    Prevalence of type 2 diabetes among global Indigenous adult populations: a systematic review.
    Diabetologia. 2025 Dec 21. doi: 10.1007/s00125-025-06624.
    >> Share

  155. NEVES JS, Leite AR, Vale C, Marques P, et al
    Efficacy of tirzepatide versus semaglutide in achieving therapeutic targets in type 2 diabetes: a post hoc analysis of the SURPASS-2 Trial.
    Diabetologia. 2025 Dec 19. doi: 10.1007/s00125-025-06637.
    >> Share

  156. QIN X, Chen S, Sun Y, Ma Z, et al
    Aberrant STING signalling promotes endothelial dysfunction and neurovascular injury in diabetic retinopathy.
    Diabetologia. 2025 Dec 19. doi: 10.1007/s00125-025-06628.
    >> Share

  157. ANJOM-SHOAE J, Fitzgerald PCE, Rose BD, Bitarafan V, et al
    Effects of combined intraduodenal administration of lauric acid and L-tryptophan on postprandial plasma glucose, glucoregulatory hormones and gastric emptying in type 2 diabetes: a double-blind, randomised, crossover study.
    Diabetologia. 2025 Dec 19. doi: 10.1007/s00125-025-06630.
    >> Share

  158. MATTILA M, Haario P, Hakola L, Takkinen HM, et al
    Dietary intake of vitamins A, B, C, D and E and risk of islet autoimmunity and type 1 diabetes in genetically at-risk children: a prospective study from the DIPP birth cohort.
    Diabetologia. 2025 Dec 19. doi: 10.1007/s00125-025-06635.
    >> Share

  159. CHIRIACO M, Trico D, Petrie JR, Gabriel R, et al
    Impact of overweight and obesity on fasting insulin secretion in men and women without diabetes: effect sizes and mechanisms.
    Diabetologia. 2025 Dec 18. doi: 10.1007/s00125-025-06643.
    >> Share

  160. ZHOU X, Sevilla-Gonzalez M, Phipps AI, Udler M, et al
    Diabetogenic processes for insulin resistance-linked hyperinsulinaemia are associated with colorectal cancer.
    Diabetologia. 2025 Dec 15. doi: 10.1007/s00125-025-06631.
    >> Share

  161. CHOI W
    Impact of normoglycaemia and prediabetes definitions on the estimated benefits of regression from prediabetes to normoglycaemia for type 2 diabetes risk.
    Diabetologia. 2025 Dec 15. doi: 10.1007/s00125-025-06636.
    >> Share

  162. JI L, Nai Y, Chen Z, Zhong Y, et al
    alpha7 Nicotinic acetylcholine receptor activation rescues mitochondrial dysfunction in gestational diabetes mellitus by competing with p66Shc for VDAC1 binding.
    Diabetologia. 2025 Dec 15. doi: 10.1007/s00125-025-06640.
    >> Share

  163. KOBAYATI A, Tsoukas MA, Garfield N, Legault L, et al
    Inter- and intra-physician variability in insulin injection adjustments compared with Bayesian algorithm recommendations in type 1 diabetes.
    Diabetologia. 2025 Dec 15. doi: 10.1007/s00125-025-06627.
    >> Share

  164. WANG Y, Ram J, Bianchi C, Fiorentino TV, et al
    Superiority of 1 h plasma glucose vs fasting plasma glucose, 2 h plasma glucose and HbA(1c) for the diagnosis of type 2 diabetes.
    Diabetologia. 2025 Dec 12. doi: 10.1007/s00125-025-06632.
    >> Share

  165. DAVOODIAN N, Lotfaliany M, Huxley RR, Lee CMY, et al
    Impact of normoglycaemia and prediabetes definitions on the estimated benefits of regression from prediabetes to normoglycaemia for type 2 diabetes risk. Reply to Choi W [Letter].
    Diabetologia. 2025 Dec 12. doi: 10.1007/s00125-025-06641.
    >> Share

  166. LI X, Gong H, Xiong C, Huang X, et al
    LDHA induces beta cell dedifferentiation in diabetes through metabolic and epigenetic reprogramming.
    Diabetologia. 2025 Dec 11. doi: 10.1007/s00125-025-06626.
    >> Share

  167. THIRUMATHYAM R, Richter EA, van Hall G, Andersen NR, et al
    Empagliflozin improves beta cell function independently of relief of glucotoxicity in patients with type 2 diabetes: results from a randomised cross-over study with insulin as comparator.
    Diabetologia. 2025 Dec 9. doi: 10.1007/s00125-025-06616.
    >> Share

  168. MCCARTHY OM, Brodsgaard RB, Tawfik S, Lundemose SB, et al
    Impact of cardiovascular autonomic neuropathy on cardiopulmonary, sympathoadrenal and metabolic responses to physical exercise in adults with type 1 diabetes.
    Diabetologia. 2025 Dec 9. doi: 10.1007/s00125-025-06619.
    >> Share

  169. VEIJOLA R, Tamura RN, Clasen JL, Elding Larsson H, et al
    Family history of type 2 diabetes delays development of type 1 diabetes in TEDDY children with islet autoimmunity.
    Diabetologia. 2025 Dec 8. doi: 10.1007/s00125-025-06613.
    >> Share

  170. DUNCAN MS, Beach LB, Wolfe HL, Restar A, et al
    Sexual orientation, gender identity and cardiometabolic risk: a narrative review.
    Diabetologia. 2025;68:2652-2669.
    >> Share

  171. SCHREMS E, Gruber JR, Schiweck C, Ruf A, et al
    Daily life stress is linked to increased glucose levels in individuals with insulin resistance: a real-world assessment.
    Diabetologia. 2025;68:2709-2718.
    >> Share

  172. LAMARCHE LB, Koch C, Khalid S, Khan MZ, et al
    Complete loss of SLC30A8 in humans improves glucose metabolism and beta cell function.
    Diabetologia. 2025;68:2754-2766.
    >> Share

  173. HO QWC, Miller JA, Gunaseelan D, Chelliah R, et al
    I-BET151 modulates glucokinase gene expression and beta cell function in part through changes in FOXO1 expression.
    Diabetologia. 2025;68:2767-2780.
    >> Share

    November 2025
  174. HIGHTON PJ, Funnell MP, Gupta P, Zaccardi F, et al
    Improving medication adherence in type 2 diabetes: strategies for better clinical and economic outcomes.
    Diabetologia. 2025 Nov 28. doi: 10.1007/s00125-025-06617.
    >> Share

  175. MATSUI S, Yamamoto T, Takabatake Y, Takahashi A, et al
    Defective autophagy and AMPK inactivation drive ferroptosis in diabetic kidney disease.
    Diabetologia. 2025 Nov 28. doi: 10.1007/s00125-025-06612.
    >> Share

  176. BANGSHAAB M, Bengtsen MB, Smedegaard S, Sondergaard E, et al
    Ketone supplementation dose-dependently lowers postprandial blood glucose, lipid and ghrelin levels in individuals with type 2 diabetes: a randomised crossover study.
    Diabetologia. 2025 Nov 28. doi: 10.1007/s00125-025-06614.
    >> Share

  177. CHO SH, Kim S, Oh R, Kim JY, et al
    High incidence of eating disorders in individuals with type 2 diabetes and their association with cardiovascular and mortality risks.
    Diabetologia. 2025 Nov 26. doi: 10.1007/s00125-025-06615.
    >> Share

  178. GUPTA L, Misra A
    From malnutrition-related diabetes mellitus to 'type 5 diabetes': phenotypic variation, not reclassification.
    Diabetologia. 2025 Nov 22. doi: 10.1007/s00125-025-06607.
    >> Share

  179. BOLDISON J, Leete P, Robinson EJ, Powell W, et al
    CXCR3 expression on antigen-experienced B cells is systemically dysregulated in type 1 diabetes.
    Diabetologia. 2025 Nov 22. doi: 10.1007/s00125-025-06608.
    >> Share

  180. TRIMBLE ER, Phillips DIW, Balcha SA
    From malnutrition-related diabetes mellitus to 'type 5 diabetes': phenotypic variation, not reclassification. Reply to Gupta L, Misra A [letter].
    Diabetologia. 2025 Nov 22. doi: 10.1007/s00125-025-06606.
    >> Share

  181. MAYNARD AG, Bhardwaj R, Jones TR, Claussnitzer M, et al
    Bridging the variant-to-function gap in type 2 diabetes: advances and challenges.
    Diabetologia. 2025 Nov 22. doi: 10.1007/s00125-025-06600.
    >> Share

  182. ZHU D, Ma J, Wang W, Shi B, et al
    Efficacy and safety of efsubaglutide alfa in individuals with type 2 diabetes (SUPER1): a randomised, double-blind, placebo-controlled, Phase IIb/III trial.
    Diabetologia. 2025 Nov 21. doi: 10.1007/s00125-025-06593.
    >> Share

  183. NERUP J, Lernmark A
    The rise and fall of a paradigm and conceiving a new hypothesis for type 1 diabetes.
    Diabetologia. 2025 Nov 21. doi: 10.1007/s00125-025-06610.
    >> Share

  184. HEIN M, Qambari H, Yu P, Mehnert A, et al
    Interpericyte tunnelling nanotube loss in very early diabetic retinal disease.
    Diabetologia. 2025 Nov 20. doi: 10.1007/s00125-025-06602.
    >> Share

  185. WOUTERS A, Lemaitre P, Degroote L, Viaene M, et al
    Redosing of anti-CD3 antibodies in NOD mice with new-onset diabetes does not alter the effect of a single treatment course.
    Diabetologia. 2025 Nov 20. doi: 10.1007/s00125-025-06604.
    >> Share

  186. BAJRAMAGIC M, Battelino T, Cos X, Cote M, et al
    Artificial intelligence-driven clinical decision support systems to assist healthcare professionals and people with diabetes in Europe at the point of care: a Delphi-based consensus roadmap.
    Diabetologia. 2025 Nov 17. doi: 10.1007/s00125-025-06601.
    >> Share

  187. ZAITOON H, Perl L, Cohen-Sela E, Oren A, et al
    The virtual Morris water maze for cognitive function assessment in adolescents with type 1 diabetes.
    Diabetologia. 2025 Nov 17. doi: 10.1007/s00125-025-06598.
    >> Share

  188. WATANABE-SHIMOJI K, Tanabe H, Ohsugi M, Kawakami E, et al
    Diverse combination of factors associated with the development of diabetic kidney disease among data-driven diabetes subtypes: analysis of the J-DREAMS registry.
    Diabetologia. 2025 Nov 17. doi: 10.1007/s00125-025-06594.
    >> Share

  189. BERGDAHL E, Forsander G, Milkovic L, Sundberg F, et al
    Influence of glycaemic management and BMI on cardiac autonomic markers in children with type 1 diabetes: a prospective cohort study.
    Diabetologia. 2025 Nov 11. doi: 10.1007/s00125-025-06592.
    >> Share

  190. SHAH VN, Xu Y, Dabiri Y, Mohanadas HP, et al
    Association of HbA(1c) and an updated glucose management indicator (uGMI) with incident diabetic retinopathy in adults with type 1 diabetes: a longitudinal study.
    Diabetologia. 2025 Nov 11. doi: 10.1007/s00125-025-06599.
    >> Share

  191. PATEL SK, Ma CS, Fourlanos S, Greenfield JR, et al
    Clinical, immunogenetic and metabolic characteristics of autoantibody-negative and autoantibody-positive type 1 diabetes.
    Diabetologia. 2025 Nov 11. doi: 10.1007/s00125-025-06580.
    >> Share

  192. FORTEATH C, Merchant HJ, Kocherry C, Murdoch CE, et al
    Recurrent hypoglycaemia promotes cardiomyopathy and cardiac vulnerability in a rodent model of type 1 diabetes.
    Diabetologia. 2025 Nov 10. doi: 10.1007/s00125-025-06574.
    >> Share

  193. JANSZ TT, Young KG, Hopkins R, McGovern AP, et al
    Precision medicine in type 2 diabetes: targeting SGLT2 inhibitor treatment for kidney protection.
    Diabetologia. 2025 Nov 9. doi: 10.1007/s00125-025-06577.
    >> Share

  194. WONG FS, Pearson JA, Wen L
    Is the NOD mouse a good model for type 1 diabetes?
    Diabetologia. 2025 Nov 8. doi: 10.1007/s00125-025-06579.
    >> Share

  195. WU CY, Sharma A, Edwards JD, Liu PP, et al
    Cardiovascular effectiveness and safety of SGLT2 inhibitors vs DPP4 inhibitors by dementia status: a cohort study of older adults with diabetes.
    Diabetologia. 2025 Nov 8. doi: 10.1007/s00125-025-06595.
    >> Share

  196. KUUSELA S, Koskenniemi JJ, Valtanen T, Pokka T, et al
    Islet autoimmunity and progression to type 1 diabetes in the Finnish DIPP study: comparison between genetically susceptible children with and without an affected first-degree relative.
    Diabetologia. 2025 Nov 8. doi: 10.1007/s00125-025-06573.
    >> Share

  197. DIMITROPOULOU NM, Beran M, Eussen SJPM, Dingena CF, et al
    Liver fat content is not elevated in people with type 1 diabetes: the Maastricht Study.
    Diabetologia. 2025 Nov 7. doi: 10.1007/s00125-025-06597.
    >> Share

  198. SCHULTZ ANO, Christensen R, Bollig G, Kidholm K, et al
    Effectiveness of video consultations in type 1 diabetes patients treated with insulin pumps in the outpatient clinic: a randomised controlled trial.
    Diabetologia. 2025 Nov 7. doi: 10.1007/s00125-025-06585.
    >> Share

  199. GITELMAN SE, Simmons K, Sherr JL, Leichter SB, et al
    Safety and pharmacokinetics of teplizumab in children less than 8 years of age with stage 2 type 1 diabetes.
    Diabetologia. 2025 Nov 6. doi: 10.1007/s00125-025-06586.
    >> Share

  200. MISRA S
    Ethnic diversity in precision medicine: a reality or an aspiration?
    Diabetologia. 2025;68:2449-2464.
    >> Share

  201. YUEN L, Hannah W, Hare M, Simmons D, et al
    Hyperglycaemia in pregnancy: the role of ethnicity and geography in risk and outcomes.
    Diabetologia. 2025;68:2340-2361.
    >> Share

  202. ANIAGYEI W, Sarfo-Kantanka O, Mohayideen S, Vivekanandan MM, et al
    Heterogeneity in clinically diagnosed type 1 diabetes: characterising a unique cohort with maintained C-peptide secretion in Ghana.
    Diabetologia. 2025 Nov 1. doi: 10.1007/s00125-025-06576.
    >> Share

    October 2025
  203. BAILEY CJ
    Pharmacological therapies for type 2 diabetes: future approaches.
    Diabetologia. 2025 Oct 31. doi: 10.1007/s00125-025-06581.
    >> Share

  204. STIMSON RH, Dover AR, Clarke C, Conceicao C, et al
    Persistent C-peptide secretion is associated with favourable CGM metrics in adults with type 1 diabetes.
    Diabetologia. 2025 Oct 30. doi: 10.1007/s00125-025-06578.
    >> Share

  205. LIU W, Deng B
    Diabetes heterogeneity beyond 3.8 years: missed risks of silent hypoglycaemia and long-term complications in the 4C study.
    Diabetologia. 2025 Oct 30. doi: 10.1007/s00125-025-06588.
    >> Share

  206. WANG S, Jia X, Yin Y, Lin H, et al
    Diabetes heterogeneity beyond 3.8 years: missed risks of silent hypoglycaemia and long-term complications in the 4C study. Reply to Liu W, Deng B [letter].
    Diabetologia. 2025 Oct 29. doi: 10.1007/s00125-025-06589.
    >> Share

  207. TOKORO MF, Mita T, Osonoi Y, Someya Y, et al
    An evening chronotype is associated with the incidence and progression of diabetic retinopathy in people with type 2 diabetes mellitus: a cohort study.
    Diabetologia. 2025 Oct 24. doi: 10.1007/s00125-025-06590.
    >> Share

  208. COLOMBIJN JMT, de Leijer JF, Visseren FLJ, Verhaar MC, et al
    Effectiveness and safety of combining SGLT2 inhibitors and GLP-1 receptor agonists in individuals with type 2 diabetes: a systematic review and meta-analysis of cohort studies.
    Diabetologia. 2025 Oct 21. doi: 10.1007/s00125-025-06565.
    >> Share

  209. ZHA D, Gamez J, Ebrahimi SM, Wang Y, et al
    Oxidative stress-regulatory role of miR-10b-5p in the diabetic human cornea revealed through integrated multi-omics analysis.
    Diabetologia. 2025 Oct 20. doi: 10.1007/s00125-025-06558.
    >> Share

  210. DAVOODIAN N, Lotfaliany M, Huxley RR, Lee CMY, et al
    Regression from prediabetes to normoglycaemia and the role of cardiometabolic risk factors on the subsequent risk of developing type 2 diabetes.
    Diabetologia. 2025 Oct 18. doi: 10.1007/s00125-025-06555.
    >> Share

  211. VERCALSTEREN E, Karampatsi D, Neicu M, Romanitan MO, et al
    Pre-stroke weight loss by glucagon-like peptide 1 receptor and neuropeptide Y receptor Y2 activation improves post-stroke functional recovery in male diabetic mouse models.
    Diabetologia. 2025 Oct 15. doi: 10.1007/s00125-025-06567.
    >> Share

  212. ZHU R, Guo J, Huttunen-Lenz M, Silvestre M, et al
    Long-term effects of dietary protein and carbohydrate quality on prediabetes remission: results from the PREVIEW randomised multinational diabetes prevention trial.
    Diabetologia. 2025 Oct 15. doi: 10.1007/s00125-025-06560.
    >> Share

  213. FAGHER K, Eeg-Olofsson K, Arnqvist H, Bolinder J, et al
    Uric acid and future complications in young individuals with type 1 diabetes: results from the Diabetes Incidence Study in Sweden (DISS) and the National Diabetes Registry of Sweden (NDR).
    Diabetologia. 2025 Oct 14. doi: 10.1007/s00125-025-06561.
    >> Share

  214. PERNG W, Shu S, Nathan DM, Luchsinger JA, et al
    Shared and distinct metabolomics profiles associated with microvascular complications in the Diabetes Prevention Program Outcomes Study.
    Diabetologia. 2025 Oct 11. doi: 10.1007/s00125-025-06571.
    >> Share

  215. MA C, Zeng H
    Methodological considerations for interpreting long-term statin use and diabetes incidence.
    Diabetologia. 2025 Oct 9. doi: 10.1007/s00125-025-06568.
    >> Share

  216. O'CONNELL MA, Beare R, Messazos B, Northam EA, et al
    Acute brain responses to hypoglycaemia and hyperglycaemia in adolescents with type 1 diabetes.
    Diabetologia. 2025 Oct 7. doi: 10.1007/s00125-025-06548.
    >> Share

  217. SLOAN G, Teh K, Greig M, Shillo P, et al
    Beyond pain relief: the effects of chronic opioid use on brain structure and function in diabetic neuropathy-a multimodal neuroimaging study.
    Diabetologia. 2025 Oct 6. doi: 10.1007/s00125-025-06529.
    >> Share

  218. BUCKLEY AJ, Tan GD, Gruszka-Goh M, Scanlon PH, et al
    No evidence that tirzepatide can worsen diabetic retinopathy. Reply to Fadini GP [letter]. Reassessing retinopathy risk with tirzepatide therapy. Reply to Zhang N, Wang W, Wan G [letter].
    Diabetologia. 2025 Oct 6. doi: 10.1007/s00125-025-06562.
    >> Share

  219. FADINI GP
    No evidence that tirzepatide can worsen diabetic retinopathy.
    Diabetologia. 2025 Oct 6. doi: 10.1007/s00125-025-06564.
    >> Share

  220. ZHANG Y, Giovannucci EL, Wang DD
    Methodological considerations for interpreting long-term statin use and diabetes incidence. Reply to Ma C, Zeng H [letter].
    Diabetologia. 2025 Oct 3. doi: 10.1007/s00125-025-06569.
    >> Share

  221. MICHALEK DA, Tern C, Robertson CC, Chen WM, et al
    HLA-focused type 1 diabetes genetic risk prediction in populations of diverse ancestry.
    Diabetologia. 2025 Oct 2. doi: 10.1007/s00125-025-06563.
    >> Share

  222. PAPADIMOS ER, Claussen C, Magliano DJ, Hotu C, et al
    Prevalence of youth type 2 diabetes in global Indigenous populations: a systematic review.
    Diabetologia. 2025 Oct 2. doi: 10.1007/s00125-025-06556.
    >> Share

  223. ALBARGOTHY MJ, Troendle EP, Laws R, Barabas P, et al
    3D electron microscopy reveals novel ultrastructural changes in the diabetic retinal neurovascular unit.
    Diabetologia. 2025 Oct 2. doi: 10.1007/s00125-025-06554.
    >> Share

  224. WHELEHAN G, Hakim O, Ladwa M, Bello O, et al
    Ethnic differences in beta cell function and pancreatic fat in Black African and White European men across a spectrum of glucose tolerance.
    Diabetologia. 2025;68:2290-2295.
    >> Share

  225. ANDERSEN AK, Lyng KD, Faerch K, Vistisen D, et al
    What are the most important research questions within prediabetes? A priority setting partnership in collaboration with patients, healthcare professionals and researchers.
    Diabetologia. 2025;68:2156-2167.
    >> Share

  226. ZHANG RX, Li AQ, Zhao XY, Wang B, et al
    Identification of SEC16B as a novel regulator of glucose homeostasis.
    Diabetologia. 2025;68:2247-2262.
    >> Share

  227. MARUCCI A, Derhourhi M, Menzaghi C, Fini G, et al
    The role of SLC19A2 variants in the wide spectrum of non-autoimmune abnormalities of glucose homeostasis.
    Diabetologia. 2025;68:2240-2246.
    >> Share

  228. DENG Y, Wu H, Ng NYH, Tam CHT, et al
    Association between maternal glucose levels in pregnancy and offspring's metabolism and adiposity: an 18-year birth cohort study.
    Diabetologia. 2025;68:2205-2216.
    >> Share

    September 2025
  229. TRIMBLE ER, Phillips DIW, Balcha SA
    Phenotype of insulin-dependent diabetes in chronic undernutrition: beta cell stress and immune dysfunction-a rural sub-Saharan perspective on type 5 diabetes.
    Diabetologia. 2025 Sep 29. doi: 10.1007/s00125-025-06553.
    >> Share

  230. ZHAO LP, Papadopoulos GK, McFarland BJ, Skyler JS, et al
    Correction: Profiling associations of interactive ligand-receptors (HLA class I and KIR gene products) with the progression to type 1 diabetes among seroconverted participants.
    Diabetologia. 2025 Sep 27. doi: 10.1007/s00125-025-06557.
    >> Share

  231. CASTELBLANCO E, Shyr ZA, Ramirez-Sotero I, Yan Z, et al
    Restoration of pancreatic beta cell identity and autophagy in K(ATP)-induced diabetes by intermittent fasting.
    Diabetologia. 2025 Sep 25. doi: 10.1007/s00125-025-06545.
    >> Share

  232. DYSON NJ, Kattner N, Al-Selwi Y, Honkanen-Scott M, et al
    Quantitative analysis of human adult pancreatic histology reveals separate fatty and fibrotic phenotypes in type 2 diabetes.
    Diabetologia. 2025 Sep 24. doi: 10.1007/s00125-025-06547.
    >> Share

  233. TOLEDO FGS, Li Y, Wang F, Bellin MD, et al
    Pancreatic cancer-related diabetes and type 2 diabetes differ in multiple aspects of glucose homeostasis.
    Diabetologia. 2025 Sep 24. doi: 10.1007/s00125-025-06543.
    >> Share

  234. KVIST AAS, Sharma A, Qvigstad E, Sattar N, et al
    Differences in tissue-specific insulin resistance between South Asian and Nordic women with prediabetes after gestational diabetes.
    Diabetologia. 2025 Sep 24. doi: 10.1007/s00125-025-06546.
    >> Share

  235. HOYER KL, Kornum DS, Baunwall SMD, Klinge MW, et al
    Repeated faecal microbiota transplantation for individuals with type 1 diabetes and gastroenteropathy.
    Diabetologia. 2025 Sep 18. doi: 10.1007/s00125-025-06544.
    >> Share

  236. DIETLER D, Bjork J, Palmkvist E, Carlsson A, et al
    Trends in type 1 diabetes incidence between 2007 and 2023 and their association with SARS-CoV-2 infection in a population-based matched cohort study among individuals under 30 years old in Sweden.
    Diabetologia. 2025 Sep 18. doi: 10.1007/s00125-025-06540.
    >> Share

  237. GIORGINO F, Alzaid F, Pantea Stoian A, Chan JCN, et al
    Global challenges in diabetes research and care: which way forward? An appraisal from the EASD Global Council.
    Diabetologia. 2025 Sep 10. doi: 10.1007/s00125-025-06504.
    >> Share

  238. CANHA D, Choudhary P, Cosson E, Banu I, et al
    Time below range alone is insufficient to identify severe hypoglycaemia risk in type 1 diabetes-the critical role of hypoglycaemia awareness: results from the SFDT1 study.
    Diabetologia. 2025 Sep 9. doi: 10.1007/s00125-025-06536.
    >> Share

  239. SUBRAMANIAN V, Sherman AS, Holst JJ, Knop FK, et al
    Evaluating the role of alpha cell dysregulation in the progression to type 2 diabetes using mathematical simulations.
    Diabetologia. 2025 Sep 9. doi: 10.1007/s00125-025-06524.
    >> Share

  240. CIVIT-URGELL A, Pena E, Bejar MT, Moscatiello F, et al
    bFGF rescues dysfunctional properties of adipose-derived stem cells from individuals with type 2 diabetes by modulating their miRNA profile.
    Diabetologia. 2025 Sep 4. doi: 10.1007/s00125-025-06533.
    >> Share

  241. GU X, Wei Y
    The relationship between shrunken pore syndrome/selective glomerular hypofiltration syndromes and all-cause mortality in the Fremantle Diabetes Study Phase II.
    Diabetologia. 2025 Sep 4. doi: 10.1007/s00125-025-06531.
    >> Share

  242. BRUCE DG, Davis WA, Chubb SAP, Davis TME, et al
    The relationship between shrunken pore syndrome/selective glomerular hypofiltration syndromes and all-cause mortality in the Fremantle Diabetes Study Phase II. Reply to Gu X, Wei Y [letter].
    Diabetologia. 2025 Sep 4. doi: 10.1007/s00125-025-06532.
    >> Share

  243. PETKOVIC M, Leal EC, Sorensen AE, Jorgensen PT, et al
    Improved wound healing by dual inhibition of miR-146a-5p and miR-29a-3p supports a network action of dysregulated miRNAs in diabetic skin.
    Diabetologia. 2025 Sep 3. doi: 10.1007/s00125-025-06522.
    >> Share

  244. MUNGKALASUT P, Chanda M, Jugnam-Ang W, Cheepsunthorn P, et al
    Glucose 6-phosphate dehydrogenase deficiency and Southeast Asian-specific mutations lower HbA(1c) levels in a Thai population: implications for diabetes diagnosis.
    Diabetologia. 2025 Sep 1. doi: 10.1007/s00125-025-06523.
    >> Share

  245. GOMEZ-MEDINA AM, Henao-Carillo DC, Villamil-Castaneda LP, Gomez-Quesada Y, et al
    Insulin DEgludec/LIraglutide versus multiple daily insulin injections in the transition from hospital to outpatient management assessed by continuous glucose monitoring: the DELI transition trial.
    Diabetologia. 2025;68:1899-1907.
    >> Share

  246. BRISNOVALI NF, Franco I, Abdelgawwad A, Tsou HLP, et al
    Effects of SGLT2 ablation or inhibition on corticosterone secretion in high-fat-fed mice: exploring a nexus with cytokine levels.
    Diabetologia. 2025;68:2042-2056.
    >> Share

  247. DIMITROPOULOU NM, Eussen SJPM, Schalkwijk CG, de Galan BE, et al
    Glucose variability measured by continuous glucose monitoring is associated with skin autofluorescence: the Maastricht Study.
    Diabetologia. 2025;68:1937-1946.
    >> Share

    August 2025
  248. JIA X, Wang S, Lin H, Zhu Y, et al
    Heterogeneity of diabetes and disease progression with a tree-like representation: findings from the China Cardiometabolic Disease and Cancer Cohort (4C) study.
    Diabetologia. 2025 Aug 30. doi: 10.1007/s00125-025-06528.
    >> Share


  249. 61(st) EASD Annual Meeting of the European Association for the Study of Diabetes : Vienna, Austria, 15 - 19 September 2025.
    Diabetologia. 2025 Aug 26. doi: 10.1007/s00125-025-06497.
    >> Share

  250. ZHAO LP, Papadopoulos GK, McFarland BJ, Skyler JS, et al
    Profiling associations of interactive ligand-receptors (HLA class I and KIR gene products) with the progression to type 1 diabetes among seroconverted participants.
    Diabetologia. 2025 Aug 21. doi: 10.1007/s00125-025-06520.
    >> Share

  251. YU MG, Shah H, Jangolla S, Gauthier J, et al
    Risk and protective factors for coronary atherosclerosis and myocardial dysfunction in individuals with long-duration type 1 diabetes.
    Diabetologia. 2025 Aug 20. doi: 10.1007/s00125-025-06521.
    >> Share

  252. SHI C, Wang X, Qin S, He A, et al
    BCKDK accelerates the progression of diabetic kidney disease by regulating leucine-mediated metabolic remodelling in renal tubular cells.
    Diabetologia. 2025 Aug 16. doi: 10.1007/s00125-025-06519.
    >> Share

  253. HUHN EA, Kotzaeridi G, Fischer T, Todesco Bernasconi M, et al
    The utility of early gestational OGTT and biomarkers for the development of gestational diabetes mellitus: an international prospective multicentre cohort study.
    Diabetologia. 2025 Aug 16. doi: 10.1007/s00125-025-06517.
    >> Share

  254. SPEKSNIJDER EM, Simsek S, Bisschop PH, Stenvers DJ, et al
    Perceived blood glucose regulation after menopause: a cross-sectional survey in women with type 1 diabetes in the Netherlands.
    Diabetologia. 2025 Aug 16. doi: 10.1007/s00125-025-06518.
    >> Share

  255. AUGUSTINE J, Troendle EP, Friedel T, Baldwin C, et al
    Scavenging acrolein with 2-HDP preserves neurovascular integrity in a rat model of diabetic retinal disease.
    Diabetologia. 2025 Aug 15. doi: 10.1007/s00125-025-06515.
    >> Share

  256. HERDER C, Pritlove C, Chaturvedi N, Mulder H, et al
    Diabetes prevention and treatment: a global perspective.
    Diabetologia. 2025 Aug 12. doi: 10.1007/s00125-025-06511.
    >> Share

  257. MYTKOLLI L, Ahmed A, Ajmal S, Alvarez Pagola A, et al
    Diabetes in four dialects: a global call for equity across lived, loved, learned and laboured experiences.
    Diabetologia. 2025 Aug 9. doi: 10.1007/s00125-025-06506.
    >> Share

  258. KENNEDY B, Wernroth ML, Langenskiold S, Bonander C, et al
    The impact of child type 1 diabetes on parental incomes in a welfare state context: quasi-experimental evidence from Swedish national registers.
    Diabetologia. 2025 Aug 8. doi: 10.1007/s00125-025-06492.
    >> Share

  259. ROTH-SCHULZE AJ, Bandala-Sanchez E, Ngui KM, Naselli G, et al
    Adverse pregnancy outcomes in women with type 1 diabetes are associated with multiple alterations in the vaginal microbiome.
    Diabetologia. 2025 Aug 7. doi: 10.1007/s00125-025-06509.
    >> Share

  260. CHATURVEDI N, Voight BF, Wells JC, Pritlove C, et al
    Race, ethnicity and ancestry in global diabetes research: grappling with complexity to advance equity and scientific integrity - a narrative review and viewpoint.
    Diabetologia. 2025 Aug 7. doi: 10.1007/s00125-025-06516.
    >> Share

  261. STENE LC
    Perspectives on prevention of type 1 diabetes and heterogeneities.
    Diabetologia. 2025 Aug 6. doi: 10.1007/s00125-025-06512.
    >> Share

  262. YAU B, Ghislain J, Kebede MA, Hughes J, et al
    The role of the beta cell in type 2 diabetes: new findings from the last 5 years.
    Diabetologia. 2025 Aug 6. doi: 10.1007/s00125-025-06499.
    >> Share

  263. PARAJULI A, Bendes A, Byvald F, Stone VM, et al
    Frequent longitudinal blood microsampling and proteome monitoring identify disease markers and enable timely intervention in a mouse model of type 1 diabetes.
    Diabetologia. 2025 Aug 4. doi: 10.1007/s00125-025-06502.
    >> Share

  264. GONG JY, Sajjadi SF, Motala AA, Shaw JE, et al
    Variation in type 2 diabetes prevalence across different populations: the key drivers.
    Diabetologia. 2025 Aug 4. doi: 10.1007/s00125-025-06478.
    >> Share

  265. WRIGHT AK, Huang T, Carr MJ, Premdayal AD, et al
    Clinical utility of self-reported sleep duration and insomnia symptoms in type 2 diabetes prediction.
    Diabetologia. 2025 Aug 2. doi: 10.1007/s00125-025-06503.
    >> Share

  266. KIM S, Park SH, Lee JA, Cho SH, et al
    Time in tight range and time in range for predicting the achievement of typical glucose management indicator and HbA(1c) targets.
    Diabetologia. 2025;68:1674-1679.
    >> Share

  267. DUTTA A, Dutta PK, Baruah SM, Dihingia P, et al
    Non-autoimmune diabetes in young people from Assam, India: the PHENOEINDY-2 study.
    Diabetologia. 2025 Aug 1. doi: 10.1007/s00125-025-06500.
    >> Share

    July 2025
  268. MUNOZ-PARDEZA J, Lopez-Gil JF, Hormazabal-Aguayo I, Huerta-Uribe N, et al
    Compositional analysis of the association between 24 h movement behaviours, HbA(1c) and interstitial glucose in children and adolescents with type 1 diabetes mellitus: a two-year longitudinal analysis of the Diactive-1 cohort study.
    Diabetologia. 2025 Jul 31. doi: 10.1007/s00125-025-06496.
    >> Share

  269. KALHAN TA, Luo M, Chai JH, Tai ES, et al
    Health economic evaluation of a risk-stratified intervention in diabetic kidney disease.
    Diabetologia. 2025 Jul 30. doi: 10.1007/s00125-025-06498.
    >> Share

  270. EVANS-MOLINA C, Dor Y, Lernmark A, Mathieu C, et al
    The heterogeneity of type 1 diabetes: implications for pathogenesis, prevention, and treatment-2024 Diabetes, Diabetes Care, and Diabetologia Expert Forum.
    Diabetologia. 2025 Jul 30. doi: 10.1007/s00125-025-06462.
    >> Share

  271. HWANG JJ, Bini J, Belfort-DeAguiar R
    Measurement of brain glucose metabolism in obesity and diabetes.
    Diabetologia. 2025 Jul 25. doi: 10.1007/s00125-025-06491.
    >> Share

  272. MORI T, Zaharia OP, Strassburger K, Dennis JM, et al
    Recognising, quantifying and accounting for classification uncertainty in type 2 diabetes subtypes.
    Diabetologia. 2025 Jul 25. doi: 10.1007/s00125-025-06486.
    >> Share

  273. LUK AOY, Fan Y, Fan B, Chow EWK, et al
    Heterogeneity in the development of diabetes-related complications: narrative review of the roles of ancestry and geographical determinants.
    Diabetologia. 2025 Jul 22. doi: 10.1007/s00125-025-06482.
    >> Share

  274. ADDALA A, Amedari MI, Figg LE, Ebekozien O, et al
    Disparities in access to and use of diabetes technologies and therapeutics: a narrative review.
    Diabetologia. 2025 Jul 22. doi: 10.1007/s00125-025-06494.
    >> Share

  275. YAMAGUCHI Y, Kuwata H, Imura M, Moyama S, et al
    Early induction of insulin sensitisation treated by tirzepatide: a prospective, single-arm, open-label study in Japanese individuals with obesity and type 2 diabetes.
    Diabetologia. 2025 Jul 22. doi: 10.1007/s00125-025-06493.
    >> Share

  276. RUSS-SILSBY J, Teles M, Hassan SS, Elbarbary NS, et al
    Global perspectives on monogenic forms of diabetes.
    Diabetologia. 2025 Jul 16. doi: 10.1007/s00125-025-06495.
    >> Share

  277. NIELSEN H, Lajeunesse-Trempe F, Lin AL, Nielsen MH, et al
    Societal and biological approaches to diabetes prevention and care for Inuit populations: a narrative review.
    Diabetologia. 2025 Jul 15. doi: 10.1007/s00125-025-06487.
    >> Share

  278. DEGROOTE L, Martens PJ, Viaene M, Heremans Y, et al
    Verapamil and low-dose anti-mouse thymocyte globulin combination therapy stably reverses recent-onset type 1 diabetes in NOD mice by acting on the beta cell and immune axes.
    Diabetologia. 2025 Jul 12. doi: 10.1007/s00125-025-06490.
    >> Share

  279. BUCKLEY AJ, Tan GD, Gruszka-Goh M, Scanlon PH, et al
    Early worsening of diabetic retinopathy in individuals with type 2 diabetes treated with tirzepatide: a real-world cohort study.
    Diabetologia. 2025 Jul 10. doi: 10.1007/s00125-025-06466.
    >> Share

  280. GUBELI A, Steiner N, Limacher A, Mathis D, et al
    Dapagliflozin's impact on hormonal regulation and ketogenesis in type 1 diabetes: a randomised controlled crossover trial.
    Diabetologia. 2025 Jul 9. doi: 10.1007/s00125-025-06481.
    >> Share

  281. HERDER C, Zhu A, Schmitt A, Spagnuolo MC, et al
    Biomarkers of inflammation and improvement in depressive symptoms in type 1 and type 2 diabetes: differential associations with depressive symptom clusters.
    Diabetologia. 2025 Jul 8. doi: 10.1007/s00125-025-06472.
    >> Share

  282. XU QH, Huang YJ
    Rethinking the link between gestational diabetes and dementia risk.
    Diabetologia. 2025 Jul 2. doi: 10.1007/s00125-025-06480.
    >> Share

  283. HENRIKSEN K, Rufer C, Title AC, Jawurek S, et al
    Proinflammatory cytokine-induced alpha cell impairment in human islet microtissues is partially restored by dual incretin receptor agonism.
    Diabetologia. 2025;68:1492-1508.
    >> Share

  284. MOEN GH, Hwang LD, Brito Nunes C, Warrington NM, et al
    The genetics of low and high birthweight and their relationship with cardiometabolic disease.
    Diabetologia. 2025;68:1452-1462.
    >> Share

  285. EHRMANN D, Krause-Steinrauf H, Uschner D, Wen H, et al
    Differential associations of somatic and cognitive-affective symptoms of depression with inflammation and insulin resistance: cross-sectional and longitudinal results from the Emotional Distress Sub-Study of the GRADE study.
    Diabetologia. 2025;68:1403-1415.
    >> Share

  286. CORBIN LJ, Merino J, Fall T, Herder C, et al
    Raising the bar for publication of Mendelian randomisation studies in Diabetologia.
    Diabetologia. 2025 Jul 1. doi: 10.1007/s00125-025-06484.
    >> Share

    June 2025
  287. KELLER MJ, Brady AJ, Smith JAB, Savikj M, et al
    Inflammatory markers and blood glucose are higher after morning vs afternoon exercise in type 2 diabetes.
    Diabetologia. 2025 Jun 28. doi: 10.1007/s00125-025-06477.
    >> Share

  288. MICHEL M, Flahault A, Coliche V, Alla A, et al
    Differences in biopsy-proven diabetic kidney disease in individuals from Polynesia vs mainland France: a retrospective cohort study.
    Diabetologia. 2025 Jun 27. doi: 10.1007/s00125-025-06471.
    >> Share

  289. PATEL K, Eastwood SV, Wells JC, Chaturvedi N, et al
    Diabetogenic elevated childhood total fat in South Asian and Black African/Caribbean people relates to adverse early life growth and low socioeconomic position compared with White people in the UK.
    Diabetologia. 2025 Jun 27. doi: 10.1007/s00125-025-06473.
    >> Share

  290. HU J, Jiang G, Qin J, Luo S, et al
    A type 1 diabetes genetic risk score discriminates between type 1 diabetes and type 2 diabetes in a Chinese population.
    Diabetologia. 2025 Jun 26. doi: 10.1007/s00125-025-06455.
    >> Share

  291. ABRAMOFF KJ, Maloney SK, Jones TW, Davis EA, et al
    Does exercise in cool water cause a higher risk of hypoglycaemia than in thermoneutral conditions in type 1 diabetes?
    Diabetologia. 2025 Jun 18. doi: 10.1007/s00125-025-06456.
    >> Share

  292. LEHNER CT, Eberl M, Donnachie E, Tanaka LF, et al
    Correction: Incidence trend of type 2 diabetes from 2012 to 2021 in Germany: an analysis of health claims data of 11 million statutorily insured people.
    Diabetologia. 2025 Jun 17. doi: 10.1007/s00125-025-06460.
    >> Share

  293. DENG Y, Tam CHT, Yang A, Shi M, et al
    Association of maternal overweight and gestational diabetes mellitus with offspring adiposity trajectory: from birth to early adolescence.
    Diabetologia. 2025 Jun 17. doi: 10.1007/s00125-025-06468.
    >> Share

  294. ZHOU Y, Hu L, Zhuang R, Song L, et al
    METRNL represses beta-to-alpha cell trans-differentiation to maintain beta cell function under diabetic metabolic stress in mice.
    Diabetologia. 2025 Jun 10. doi: 10.1007/s00125-025-06459.
    >> Share

  295. GUYER P, Seminova K, Lugar M, Manganaro A, et al
    T cell and autoantibody recognition of nucleus-associated islet autoantigens in individuals with type 1 diabetes.
    Diabetologia. 2025 Jun 9. doi: 10.1007/s00125-025-06458.
    >> Share

  296. BENNET L, Agyemang C
    Prevention of type 2 diabetes in migrant populations from low- and middle-income countries living in high-income countries.
    Diabetologia. 2025 Jun 7. doi: 10.1007/s00125-025-06465.
    >> Share

  297. COSTABILE G, Salamone D, Della Pepa G, Testa R, et al
    ApoC-III and ectopic fat accumulation in individuals with type 2 diabetes: an exploratory analysis from the MEDEA randomised controlled study.
    Diabetologia. 2025 Jun 5. doi: 10.1007/s00125-025-06464.
    >> Share

  298. DEKKER E, de Winter TJJ, Munoz Garcia A, de Graaf N, et al
    BMP5 signalling in beta cells and the impact on insulin secretion in the context of type 2 diabetes.
    Diabetologia. 2025 Jun 5. doi: 10.1007/s00125-025-06457.
    >> Share

  299. KUO CC, Chuang MH, Li CH, Tsai YW, et al
    Glucagon-like peptide-1 receptor agonists and gastrointestinal cancer risk in individuals with type 2 diabetes.
    Diabetologia. 2025 Jun 5. doi: 10.1007/s00125-025-06453.
    >> Share

  300. ALZAID F, Fagherazzi G, Riveline JP, Bahman F, et al
    Immune cell-adipose tissue crosstalk in metabolic diseases with a focus on type 1 diabetes.
    Diabetologia. 2025 Jun 4. doi: 10.1007/s00125-025-06437.
    >> Share

  301. EL TOBGY NA, Grewal EK, Gonzalez PM, Tibebu T, et al
    Interventions to improve diabetes care and self-management for individuals experiencing homelessness: a scoping review with systematic search of qualitative and quantitative literature.
    Diabetologia. 2025 Jun 3. doi: 10.1007/s00125-025-06449.
    >> Share

  302. SWENSEN AC, Piehowski PD, Chen J, Chan XY, et al
    Increased inflammation as well as decreased endoplasmic reticulum stress and translation differentiate pancreatic islets from donors with pre-symptomatic stage 1 type 1 diabetes and non-diabetic donors.
    Diabetologia. 2025 Jun 2. doi: 10.1007/s00125-025-06417.
    >> Share

  303. KALE A, Azar M, Cheng V, Robertson H, et al
    Regulating islet stress responses through CD47 activation.
    Diabetologia. 2025;68:1279-1297.
    >> Share

  304. CHEBII VJ, Wade AN, Crowther NJ, Nonterah EA, et al
    Genome-wide association study identifying novel risk variants associated with glycaemic traits in the continental African AWI-Gen cohort.
    Diabetologia. 2025;68:1184-1196.
    >> Share

    May 2025
  305. O'NEILL S, Bidulka P, Lugo-Palacios DG, Carroll O, et al
    Comparative effectiveness of alternative second-line oral glucose-lowering therapies for type 2 diabetes: a precision medicine approach applied to routine data.
    Diabetologia. 2025 May 31. doi: 10.1007/s00125-025-06447.
    >> Share

  306. MARTINENGHI S, Merolla A, Grogan P, Bianconi E, et al
    Prevention of diabetic ketoacidosis in relatives screened for islet autoantibodies and followed up in the TrialNet Pathway to Prevention study at a single institution in Italy.
    Diabetologia. 2025 May 29. doi: 10.1007/s00125-025-06461.
    >> Share

  307. HOLT RIG, Tsapas A, Meireles M, Mulder H, et al
    Clinical guidelines and other guidance from the European Association for the Study of Diabetes (EASD).
    Diabetologia. 2025 May 26. doi: 10.1007/s00125-025-06378.
    >> Share

  308. MEIRELES M, Holt RIG, Tsapas A, Mulder H, et al
    The new era of European Association for the Study of Diabetes (EASD) clinical guidance documents.
    Diabetologia. 2025 May 26. doi: 10.1007/s00125-025-06452.
    >> Share

  309. KARAGIANNIS T, Advani A, Davies MJ, Del Prato S, et al
    European Association for the Study of Diabetes (EASD) Standard Operating Procedure for the development of guidelines.
    Diabetologia. 2025 May 26. doi: 10.1007/s00125-025-06370.
    >> Share

  310. HENI M, Fruhwald L, Karges W, Naudorf M, et al
    Heterogeneity in response to GLP-1 receptor agonists in type 2 diabetes in real-world clinical practice: insights from the DPV register - an IMI-SOPHIA study.
    Diabetologia. 2025 May 22. doi: 10.1007/s00125-025-06448.
    >> Share

  311. MOLLER PM, Kjobsted R, Petersen MH, de Almeida ME, et al
    Effect of acute exercise and exercise training on the ability of insulin to clear branched-chain amino acids from plasma in obesity and type 2 diabetes.
    Diabetologia. 2025 May 22. doi: 10.1007/s00125-025-06454.
    >> Share

  312. GOULDING RP, Charlton BT, Breedveld EA, Huijts JY, et al
    Skeletal muscle mitochondrial health in type 1 diabetes: the role of exercise capacity and lifestyle factors.
    Diabetologia. 2025 May 21. doi: 10.1007/s00125-025-06451.
    >> Share

  313. FERRAT LA, Templeman EL, Steck AK, Parikh HM, et al
    Type 1 diabetes prediction in autoantibody-positive individuals: performance, time and money matter.
    Diabetologia. 2025 May 10. doi: 10.1007/s00125-025-06434.
    >> Share

  314. LINGVAY I, Benamar M, Chen L, Fu A, et al
    Correction: Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial.
    Diabetologia. 2025 May 5. doi: 10.1007/s00125-025-06435.
    >> Share

  315. LIM CE, Pasternak B, Eliasson B, Ueda P, et al
    Treatment discontinuation among users of GLP-1 receptor agonists and SGLT2 inhibitors in a national population of individuals with type 2 diabetes.
    Diabetologia. 2025 May 2. doi: 10.1007/s00125-025-06439.
    >> Share

  316. TAYLOR R
    Aetiology of type 2 diabetes: an experimental medicine odyssey.
    Diabetologia. 2025 May 2. doi: 10.1007/s00125-025-06428.
    >> Share

  317. ZHANG Y, Li Y, Liu Y, Willett WC, et al
    Duration and type of statin use and long-term risk of type 2 diabetes among men and women with hypercholesterolaemia: findings from three prospective cohorts.
    Diabetologia. 2025 May 2. doi: 10.1007/s00125-025-06441.
    >> Share

  318. CIANGURA C, Seco A, Saint-Martin C, Ancel PY, et al
    Pregnancy and neonatal outcomes in women with GCK-MODY: an observational study based on standardised insulin modalities.
    Diabetologia. 2025;68:981-992.
    >> Share

    April 2025
  319. SAGAR RC, Yates DM, Pearson SM, Kietsiriroje N, et al
    Insulin resistance in type 1 diabetes is a key modulator of platelet hyperreactivity.
    Diabetologia. 2025 Apr 30. doi: 10.1007/s00125-025-06429.
    >> Share

  320. ADESHARA K, Parente EB, Harjutsalo V, Lehto M, et al
    Relationship between sRAGE and obesity in individuals with type 1 diabetes during a median follow-up of 6.3 years.
    Diabetologia. 2025 Apr 29. doi: 10.1007/s00125-025-06440.
    >> Share

  321. PURVIS GSD, Chiazza F, Chen J, Azevedo-Loiola R, et al
    Retraction Note: Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes.
    Diabetologia. 2025 Apr 29. doi: 10.1007/s00125-025-06418.
    >> Share

  322. LEWIS CTA, Moreno-Justicia R, Savoure L, Calvo E, et al
    Dysregulated skeletal muscle myosin super-relaxation and energetics in male participants with type 2 diabetes mellitus.
    Diabetologia. 2025 Apr 28. doi: 10.1007/s00125-025-06436.
    >> Share

  323. EEG-OLOFSSON K, Nathanson D, Spelman T, Kyhlstedt M, et al
    Severe hypoglycaemia is associated with increased risk of adverse cardiovascular complications in adults with type 1 diabetes: risk mitigation using intermittently scanned continuous glucose monitoring.
    Diabetologia. 2025 Apr 24. doi: 10.1007/s00125-025-06438.
    >> Share

  324. ZHOU J, Mychaleckyj JC, Onengut-Gumuscu S, Orchard TJ, et al
    DNA methylation and 28 year incidence of two neuropathy phenotypes in type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications cohort study.
    Diabetologia. 2025 Apr 23. doi: 10.1007/s00125-025-06427.
    >> Share

  325. BRUCE DG, Davis WA, Chubb SAP, Davis TME, et al
    The relationship between shrunken pore syndrome and all-cause mortality in people with type 2 diabetes and normal renal function: the Fremantle Diabetes Study Phase II.
    Diabetologia. 2025 Apr 21. doi: 10.1007/s00125-025-06430.
    >> Share

  326. BOULTON AJM, Jenkins AJ, Makkar B, Mankovsky B, et al
    Diabetes and natural and man-made disasters: prevention, preparation, response and recovery.
    Diabetologia. 2025 Apr 15. doi: 10.1007/s00125-025-06406.
    >> Share

  327. ZAPARDIEL-GONZALO J, Ziegler AG, Bonifacio E
    The genetic architecture of type 1 diabetes over time: how well can we rely on past data to predict the future?
    Diabetologia. 2025 Apr 12. doi: 10.1007/s00125-025-06422.
    >> Share

  328. SCHAIN M, Johansson E, Laitinen I, Froden Lowenmark A, et al
    Alterations in cerebral perfusion and substrate metabolism in type 2 diabetes: interactions with APOE-epsilon4.
    Diabetologia. 2025 Apr 11. doi: 10.1007/s00125-025-06405.
    >> Share

  329. BANGSHAAB M, Svart MV, Rittig N, Pedersen MGB, et al
    Metabolic effects of 3-hydroxybutyrate infusion in individuals with type 1 diabetes compared with healthy control participants: a randomised crossover trial showing intact feedback suppression of lipolysis.
    Diabetologia. 2025 Apr 10. doi: 10.1007/s00125-025-06423.
    >> Share

  330. PRASAD RB, Hakaste L, Tuomi T
    Clinical use of polygenic scores in type 2 diabetes: challenges and possibilities.
    Diabetologia. 2025 Apr 5. doi: 10.1007/s00125-025-06419.
    >> Share

  331. VELMURUGAN S, Pandey VK, Verma N, Kotiya D, et al
    Cardiac remodelling, recognition memory deficits and accelerated ageing in a rat model of gestational diabetes.
    Diabetologia. 2025 Apr 5. doi: 10.1007/s00125-025-06421.
    >> Share

  332. RIDDELL MC, Heller S, Carstensen L, Rocha TMP, et al
    The effect of once-weekly insulin icodec vs once-daily basal insulin on physical activity-attributed hypoglycaemia in type 2 diabetes: a post hoc analysis of ONWARDS 1-5.
    Diabetologia. 2025 Apr 5. doi: 10.1007/s00125-025-06414.
    >> Share

    March 2025
  333. KAYA S, Khamees A, Geerling G, Strzalkowski P, et al
    Macular perfusion alterations in people with recent-onset diabetes and novel diabetes subtypes.
    Diabetologia. 2025 Mar 31. doi: 10.1007/s00125-025-06407.
    >> Share

  334. MONTGOMERY MK, Lin S, Yang CH, Prasad K, et al
    HEXA-FC protein therapy increases skeletal muscle glucose uptake and improves glycaemic control in mice with insulin resistance and in a mouse model of type 2 diabetes.
    Diabetologia. 2025 Mar 29. doi: 10.1007/s00125-025-06413.
    >> Share

  335. DELIYANTI D, Suphapimol V, Joglekar A, Jayasimhan A, et al
    Immunotherapy with low-dose IL-2 attenuates vascular injury in mice with diabetic and neovascular retinopathy by restoring the balance between Foxp3(+) Tregs and CD8(+) T cells.
    Diabetologia. 2025 Mar 25. doi: 10.1007/s00125-025-06412.
    >> Share

  336. MORIERI ML, Rigato M, Frison V, D'Ambrosio M, et al
    Early weight loss, diabetes remission and long-term trajectory after diagnosis of type 2 diabetes: a retrospective study.
    Diabetologia. 2025 Mar 22. doi: 10.1007/s00125-025-06402.
    >> Share

  337. BONIFACIO E, Coelho R, Ewald DA, Gemulla G, et al
    The efficacy of islet autoantibody screening with or without genetic pre-screening strategies for the identification of presymptomatic type 1 diabetes.
    Diabetologia. 2025 Mar 19. doi: 10.1007/s00125-025-06408.
    >> Share

  338. LAIHO JE, Oikarinen S, Morfopoulou S, Oikarinen M, et al
    Detection of enterovirus RNA in pancreas and lymphoid tissues of organ donors with type 1 diabetes.
    Diabetologia. 2025 Mar 17. doi: 10.1007/s00125-025-06359.
    >> Share

  339. RODRIGUEZ-CALVO T, Laiho JE, Oikarinen M, Akhbari P, et al
    Enterovirus VP1 protein and HLA class I hyperexpression in pancreatic islet cells of organ donors with type 1 diabetes.
    Diabetologia. 2025 Mar 17. doi: 10.1007/s00125-025-06384.
    >> Share

  340. RICHARDSON SJ, Rodriguez-Calvo T, Laiho JE, Kaddis JS, et al
    Joint analysis of the nPOD-Virus Group data: the association of enterovirus with type 1 diabetes is supported by multiple markers of infection in pancreas tissue.
    Diabetologia. 2025 Mar 17. doi: 10.1007/s00125-025-06401.
    >> Share

  341. LEE H, Fernandes M, Lee J, Merino J, et al
    Exploring the shared genetic landscape of diabetes and cardiovascular disease: findings and future implications.
    Diabetologia. 2025 Mar 15. doi: 10.1007/s00125-025-06403.
    >> Share

  342. YANG Q, Zhu PW, Wen YJ, Zhang R, et al
    MAP4K4 aggravates microvascular anomalies in diabetic retinopathy in a YTHDF2-dependent manner.
    Diabetologia. 2025 Mar 12. doi: 10.1007/s00125-025-06398.
    >> Share

  343. PITT M, Olvera-Barrios A, Anderson J, Bolter L, et al
    A simple score-based strategy to improve equity of the UK biennial diabetic eye screening protocol among people deemed as low risk.
    Diabetologia. 2025 Mar 12. doi: 10.1007/s00125-025-06379.
    >> Share

  344. ZHANG N, Sun Q, Zhang J, Zhang R, et al
    Intrapancreatic adipocytes and beta cell dedifferentiation in human type 2 diabetes.
    Diabetologia. 2025 Mar 12. doi: 10.1007/s00125-025-06392.
    >> Share

  345. SORENSEN KV, Justesen JM, Angquist L, Bork-Jensen J, et al
    Rare MTNR1B variants causing diminished MT2 signalling associate with elevated HbA(1c) levels but not with type 2 diabetes.
    Diabetologia. 2025 Mar 10. doi: 10.1007/s00125-025-06381.
    >> Share

  346. ZURIAGA MA, Fuster JJ
    Clonal haematopoiesis of indeterminate potential: an emerging risk factor for type 2 diabetes and related complications.
    Diabetologia. 2025 Mar 10. doi: 10.1007/s00125-025-06393.
    >> Share

  347. PLENGVIDHYA N, Suthon S, Nakdontri T, Teerawattanapong N, et al
    Correction: Islet autoantibodies in Thai individuals diagnosed with type 1 diabetes before 30 years of age: a large multicentre nationwide study.
    Diabetologia. 2025 Mar 10. doi: 10.1007/s00125-025-06404.
    >> Share

  348. TSOI AT, Sng J, Tummanapalli SS, Issar T, et al
    Metformin therapy modifies corneal neuroimmune abnormalities in people with type 2 diabetes.
    Diabetologia. 2025 Mar 7. doi: 10.1007/s00125-025-06399.
    >> Share

  349. YIN W, Zou S, Sha M, Sun L, et al
    Gain of pancreatic beta cell-specific SCD1 improves glucose homeostasis by maintaining functional beta cell mass under metabolic stress.
    Diabetologia. 2025;68:629-645.
    >> Share

  350. REDONDO MJ, Cuthbertson D, Steck AK, Herold KC, et al
    Characteristics of autoantibody-positive individuals without high-risk HLA-DR4-DQ8 or HLA-DR3-DQ2 haplotypes.
    Diabetologia. 2025;68:588-601.
    >> Share

  351. MORALES DD, Ryu J, Wei C, Hadley JT, et al
    Diet-enhanced LRG1 expression promotes insulin hypersecretion and ER stress in pancreatic beta cells.
    Diabetologia. 2025;68:615-628.
    >> Share

  352. WANG Q, Leask MP, Lee K, Jaiswal J, et al
    The population-specific Thr44Met OCT3 coding variant affects metformin pharmacokinetics with subsequent effects on insulin sensitivity in C57Bl/6J mice.
    Diabetologia. 2025;68:537-548.
    >> Share

    February 2025
  353. MOULDER R, Hirvonen MK, Valikangas T, Suomi T, et al
    Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes affirms markers of disease.
    Diabetologia. 2025 Feb 28. doi: 10.1007/s00125-025-06394.
    >> Share

  354. KOFOD DH, Diederichsen SZ, Bomholt T, Andersen MO, et al
    Cardiac arrhythmia and hypoglycaemia among individuals with and without diabetes receiving haemodialysis (the CADDY study): a Danish multicentre cohort study.
    Diabetologia. 2025 Feb 28. doi: 10.1007/s00125-025-06388.
    >> Share

  355. SIMS EK, Cuthbertson D, Ferrat LA, Bosi E, et al
    IA-2A positivity increases risk of progression within and across established stages of type 1 diabetes.
    Diabetologia. 2025 Feb 28. doi: 10.1007/s00125-025-06382.
    >> Share

  356. DING S, Xu JL, Tong JY, Cheng YY, et al
    Brown adipose tissue alleviates podocyte apoptosis through NRG4 in a male mouse model of diabetic kidney disease.
    Diabetologia. 2025 Feb 27. doi: 10.1007/s00125-025-06385.
    >> Share

  357. VERSCHUEREN VAN REES N, Ashwin P, McMullan C, Krogvold L, et al
    Beyond the loss of beta cells: a quantitative analysis of islet architecture in adults with and without type 1 diabetes.
    Diabetologia. 2025 Feb 26. doi: 10.1007/s00125-025-06376.
    >> Share

  358. CARLSSON PO, Espes D, Sisay S, Davies LC, et al
    Correction: Umbilical cord-derived mesenchymal stromal cells preserve endogenous insulin production in type 1 diabetes: a Phase I/II randomised double-blind placebo-controlled trial.
    Diabetologia. 2025 Feb 25. doi: 10.1007/s00125-025-06371.
    >> Share

  359. XIAO Q, Feng Q, Rutter MK, Albalak G, et al
    Associations between the timing of 24 h physical activity and diabetes mellitus: results from a nationally representative sample of the US population.
    Diabetologia. 2025 Feb 21. doi: 10.1007/s00125-025-06368.
    >> Share

  360. PLENGVIDHYA N, Suthon S, Nakdontri T, Teerawattanapong N, et al
    Islet autoantibodies in Thai individuals individuals diagnosed with type 1 diabetes before 30 years of age: a large multicentre nationwide study.
    Diabetologia. 2025 Feb 19. doi: 10.1007/s00125-025-06373.
    >> Share

  361. VENKATARAGHAVAN S, Pankow JS, Boerwinkle E, Fornage M, et al
    Epigenome-wide association study of incident type 2 diabetes in Black and White participants from the Atherosclerosis Risk in Communities Study.
    Diabetologia. 2025 Feb 19. doi: 10.1007/s00125-024-06352.
    >> Share

  362. JONES DL, Kusinski LC, Gillies C, Meek CL, et al
    How should we define subtypes of gestational diabetes mellitus? Reply to Gobl C, Tura A [letter].
    Diabetologia. 2025 Feb 15. doi: 10.1007/s00125-025-06375.
    >> Share

  363. GOBL C, Tura A
    How should we define subtypes of gestational diabetes mellitus?
    Diabetologia. 2025 Feb 15. doi: 10.1007/s00125-025-06374.
    >> Share

  364. PHILLIP M, Achenbach P, Addala A, Albanese-O'Neill A, et al
    Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Reply to Mallone R [letter].
    Diabetologia. 2025 Feb 12. doi: 10.1007/s00125-024-06350.
    >> Share

  365. KORNUM DS, Krogh K, Keller J, Malagelada C, et al
    Diabetic gastroenteropathy: a pan-alimentary complication.
    Diabetologia. 2025 Feb 11. doi: 10.1007/s00125-025-06365.
    >> Share

  366. CALHOUN P, Spanbauer C, Steck AK, Frohnert BI, et al
    Continuous glucose monitor metrics from five studies identify participants at risk for type 1 diabetes development.
    Diabetologia. 2025 Feb 11. doi: 10.1007/s00125-025-06362.
    >> Share

  367. DE MEULEMEESTER J, Keymeulen B, De Block C, Van Huffel L, et al
    One-year real-world benefits of Tandem Control-IQ technology on glucose management and person-reported outcomes in adults with type 1 diabetes: a prospective observational cohort study.
    Diabetologia. 2025 Feb 11. doi: 10.1007/s00125-025-06366.
    >> Share

  368. KOWALL B, Rathmann W
    Partnership and marriage and risk of type 2 diabetes: a narrative review.
    Diabetologia. 2025 Feb 7. doi: 10.1007/s00125-025-06360.
    >> Share

  369. LIN YK, Ye W, Hepworth E, Agni A, et al
    Characterising impaired awareness of hypoglycaemia and associated risks through HypoA-Q: findings from a T1D Exchange cohort.
    Diabetologia. 2025;68:433-443.
    >> Share

  370. HANSEN AL, Christiansen CF, Brons C, Engelhard LM, et al
    Birthweight and risk of chronic kidney disease after a type 2 diabetes diagnosis in the DD2 cohort.
    Diabetologia. 2025 Feb 1. doi: 10.1007/s00125-024-06357.
    >> Share

    January 2025
  371. FAN KS, Manoli A, Baumann PM, Shojaee-Moradie F, et al
    Comparison of continuous glucose monitoring with self-monitoring of blood glucose in type 1 diabetes in the changing atmospheric pressures in aviation: a hypobaric flight simulation.
    Diabetologia. 2025 Jan 31. doi: 10.1007/s00125-025-06364.
    >> Share

  372. ZHUANG S, Sun N, Qu J, Chen Q, et al
    High glucose/ChREBP-induced Hif-1alpha transcriptional activation in CD4(+) T cells reduces the risk of diabetic kidney disease by inhibiting the Th1 response.
    Diabetologia. 2025 Jan 30. doi: 10.1007/s00125-024-06354.
    >> Share

  373. FLOYD JL, Prasad R, Dupont MD, Adu-Rutledge Y, et al
    Intestinal neutrophil extracellular traps promote gut barrier damage exacerbating endotoxaemia, systemic inflammation and progression of diabetic retinopathy in type 2 diabetes.
    Diabetologia. 2025 Jan 28. doi: 10.1007/s00125-024-06349.
    >> Share

  374. MUELLER J, Breeze P, Fusco F, Sharp SJ, et al
    Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagn
    Diabetologia. 2025 Jan 23. doi: 10.1007/s00125-024-06355.
    >> Share

  375. COLLINS J, Farnsworth NL
    Active targeting of type 1 diabetes therapies to pancreatic beta cells using nanocarriers.
    Diabetologia. 2025 Jan 23. doi: 10.1007/s00125-024-06356.
    >> Share

  376. MENDOZA K, Barquera S, Tobias DK
    Targeting ultra-processed foods for prevention of type 2 diabetes: state of the evidence and future directions.
    Diabetologia. 2025 Jan 18. doi: 10.1007/s00125-025-06358.
    >> Share

  377. LINGVAY I, Benamar M, Chen L, Fu A, et al
    Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial.
    Diabetologia. 2025 Jan 17. doi: 10.1007/s00125-024-06348.
    >> Share

  378. CHEN Z, Qian F, Liu B, Zong G, et al
    Monounsaturated fatty acids from plant or animal sources and risk of type 2 diabetes in three large prospective cohorts of men and women.
    Diabetologia. 2025 Jan 14. doi: 10.1007/s00125-024-06353.
    >> Share

  379. PACHECO LS, Tobias DK, Haslam DE, Drouin-Chartier JP, et al
    Sugar-sweetened or artificially sweetened beverage consumption, physical activity and risk of type 2 diabetes in US adults.
    Diabetologia. 2025 Jan 8. doi: 10.1007/s00125-024-06351.
    >> Share

  380. HIRVELA L, Haukka J, Keski-Rahkonen A, Sipila PN, et al
    Eating disorders among people with and without type 1 diabetes: incidence and treatment in a nationwide population-based cohort.
    Diabetologia. 2025 Jan 4. doi: 10.1007/s00125-024-06346.
    >> Share

  381. CHIMIENTI R, Torchio S, Siracusano G, Zamarian V, et al
    A WFS1 variant disrupting acceptor splice site uncovers the impact of alternative splicing on beta cell apoptosis in a patient with Wolfram syndrome.
    Diabetologia. 2025;68:128-151.
    >> Share

  382. FU Q, Dai H, Shen S, He Y, et al
    Interactions of genes with alcohol consumption affect insulin sensitivity and beta cell function.
    Diabetologia. 2025;68:116-127.
    >> Share

  383. AHN M, Dhawan S, McCown EM, Garcia PA, et al
    Beta cell-specific PAK1 enrichment ameliorates diet-induced glucose intolerance in mice by promoting insulin biogenesis and minimising beta cell apoptosis.
    Diabetologia. 2025;68:152-165.
    >> Share

    December 2024
  384. NADEAU KJ, Arslanian SA, Bacha F, Caprio S, et al
    Insulin clearance at randomisation and in response to treatment in youth with type 2 diabetes: a secondary analysis of the TODAY randomised clinical trial.
    Diabetologia. 2024 Dec 20. doi: 10.1007/s00125-024-06327.
    >> Share

  385. COLE A, Weight N, Misra S, Grapsa J, et al
    Correction: Addressing disparities in the long-term mortality risk in individuals with non-ST segment myocardial infarction (NSTEMI) by diabetes mellitus status: a nationwide cohort study.
    Diabetologia. 2024 Dec 20. doi: 10.1007/s00125-024-06337.
    >> Share

  386. SHAPIRO MR, Tallon EM, Brown ME, Posgai AL, et al
    Leveraging artificial intelligence and machine learning to accelerate discovery of disease-modifying therapies in type 1 diabetes.
    Diabetologia. 2024 Dec 19. doi: 10.1007/s00125-024-06339.
    >> Share

  387. WERNROTH ML, Kennedy B, Fall K, Nguyen D, et al
    Bereavement and type 1 diabetes in childhood: a register-based cohort study in Sweden.
    Diabetologia. 2024 Dec 19. doi: 10.1007/s00125-024-06340.
    >> Share

  388. BITARAFAN V, Anjom-Shoae J, Rezaie P, Fitzgerald PCE, et al
    Dose-related effects of intraduodenal quinine on plasma glucose, glucoregulatory hormones and gastric emptying of a nutrient drink, and energy intake, in men with type 2 diabetes: a double-blind, randomised, crossover study.
    Diabetologia. 2024 Dec 18. doi: 10.1007/s00125-024-06344.
    >> Share

  389. KRISTENSEN FPB, Domazet SL, Nielsen JS, Stidsen JV, et al
    Elevated risk of infection in individuals with hyperinsulinaemic type 2 diabetes: a Danish 12 year cohort study.
    Diabetologia. 2024 Dec 11. doi: 10.1007/s00125-024-06342.
    >> Share

  390. PERKINS BA, Turner LV, Riddell MC
    Correction: Applying technologies to simplify strategies for exercise in type 1 diabetes.
    Diabetologia. 2024 Dec 11. doi: 10.1007/s00125-024-06317.
    >> Share

  391. SMEIJER JD, de Vries ST, Kohan DE, Hou FF, et al
    Sex differences in response to the endothelin receptor antagonist atrasentan in individuals with type 2 diabetes and chronic kidney disease: a post hoc analysis of the SONAR trial.
    Diabetologia. 2024 Dec 11. doi: 10.1007/s00125-024-06326.
    >> Share

  392. DE VRIES ST, Pena MJ, Tye SC, Peters SAE, et al
    Sex differences in the efficacy of angiotensin receptor blockers on kidney and cardiovascular outcomes among individuals with type 2 diabetes and diabetic kidney disease: post hoc analyses of the RENAAL and IDNT trials.
    Diabetologia. 2024 Dec 10. doi: 10.1007/s00125-024-06325.
    >> Share

  393. MOSER O, Zaharieva DP, Adolfsson P, Battelino T, et al
    The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a position statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPA
    Diabetologia. 2024 Dec 10. doi: 10.1007/s00125-024-06308.
    >> Share

  394. BROWN ME, Thirawatananond P, Peters LD, Kern EJ, et al
    Inhibition of CD226 co-stimulation suppresses diabetes development in the NOD mouse by augmenting regulatory T cells and diminishing effector T cell function.
    Diabetologia. 2024 Dec 5. doi: 10.1007/s00125-024-06329.
    >> Share

  395. MACKENBACH JD, Stuber JM, Beulens JWJ
    Evidence on the effectiveness and equity of population-based policies to reduce the burden of type 2 diabetes: a narrative review.
    Diabetologia. 2024 Dec 2. doi: 10.1007/s00125-024-06330.
    >> Share

  396. JONES DL, Kusinski LC, Gillies C, Meek CL, et al
    A critique of measurement of defective insulin secretion and insulin sensitivity as a precision approach to gestational diabetes.
    Diabetologia. 2024 Dec 2. doi: 10.1007/s00125-024-06334.
    >> Share

  397. VIRTANEN JK, Hantunen S, Kallio N, Lamberg-Allardt C, et al
    The effect of vitamin D(3) supplementation on the incidence of type 2 diabetes in healthy older adults not at high risk for diabetes (FIND): a randomised controlled trial.
    Diabetologia. 2024 Dec 2. doi: 10.1007/s00125-024-06336.
    >> Share

  398. CHEN Y, Torta F, Koh HWL, Benke PI, et al
    Metabolomics profiling in multi-ancestral individuals with type 2 diabetes in Singapore identified metabolites associated with renal function decline.
    Diabetologia. 2024 Dec 2. doi: 10.1007/s00125-024-06324.
    >> Share

  399. ZEMSKI BERRY KA, Garfield A, Jambal P, Zarini S, et al
    Oxidised phosphatidylcholine induces sarcolemmal ceramide accumulation and insulin resistance in skeletal muscle.
    Diabetologia. 2024;67:2819-2832.
    >> Share

  400. WAT LW, Svensson KJ
    Novel secreted regulators of glucose and lipid metabolism in the development of metabolic diseases.
    Diabetologia. 2024;67:2626-2636.
    >> Share

    November 2024
  401. TRICO D, Sacchetta L, Rebelos E, Cimbalo N, et al
    Postprandial hypoglycaemia after gastric bypass in type 2 diabetes: pathophysiological mechanisms and clinical implications.
    Diabetologia. 2024 Nov 29. doi: 10.1007/s00125-024-06312.
    >> Share

  402. GALDERISI A, Carr ALJ, Martino M, Taylor P, et al
    Correction: Quantifying beta cell function in the preclinical stages of type 1 diabetes.
    Diabetologia. 2024 Nov 27. doi: 10.1007/s00125-024-06335.
    >> Share

  403. HANICK CJ, Peterson CM, Davis BC, Sabate J, et al
    Correction: A whole-food, plant-based intensive lifestyle intervention improves glycaemic control and reduces medications in individuals with type 2 diabetes: a randomised controlled trial.
    Diabetologia. 2024 Nov 25. doi: 10.1007/s00125-024-06332.
    >> Share

  404. O CK, Fan B, Tsoi STF, Tam CHT, et al
    A polygenic risk score derived from common variants of monogenic diabetes genes is associated with young-onset type 2 diabetes and cardiovascular-kidney complications.
    Diabetologia. 2024 Nov 23. doi: 10.1007/s00125-024-06320.
    >> Share

  405. GALDERISI A, Sims EK, Evans-Molina C, Petrelli A, et al
    Trajectory of beta cell function and insulin clearance in stage 2 type 1 diabetes: natural history and response to teplizumab.
    Diabetologia. 2024 Nov 19. doi: 10.1007/s00125-024-06323.
    >> Share

  406. LAESSER CI, Piazza C, Schorno N, Nick F, et al
    Simplified meal announcement study (SMASH) using hybrid closed-loop insulin delivery in youth and young adults with type 1 diabetes: a randomised controlled two-centre crossover trial.
    Diabetologia. 2024 Nov 19. doi: 10.1007/s00125-024-06319.
    >> Share

  407. YU G, Tam CHT, Lim CKP, Shi M, et al
    Type 2 diabetes pathway-specific polygenic risk scores elucidate heterogeneity in clinical presentation, disease progression and diabetic complications in 18,217 Chinese individuals with type 2 diabetes.
    Diabetologia. 2024 Nov 12. doi: 10.1007/s00125-024-06309.
    >> Share

  408. ROONEY MR, Wallace AS, Echouffo Tcheugui JB, Fang M, et al
    Prediabetes is associated with elevated risk of clinical outcomes even without progression to diabetes.
    Diabetologia. 2024 Nov 12. doi: 10.1007/s00125-024-06315.
    >> Share

  409. PHILLIPS NE, Mareschal J, Biancolin AD, Sinturel F, et al
    The metabolic and circadian signatures of gestational diabetes in the postpartum period characterised using multiple wearable devices.
    Diabetologia. 2024 Nov 12. doi: 10.1007/s00125-024-06318.
    >> Share

  410. WANG E, Patorno E, Khosrow-Khavar F, Crystal S, et al
    Racial and ethnic disparities in the uptake of SGLT2is and GLP-1RAs among Medicare beneficiaries with type 2 diabetes and heart failure, atherosclerotic cardiovascular disease and chronic kidney disease, 2013-2019.
    Diabetologia. 2024 Nov 8. doi: 10.1007/s00125-024-06321.
    >> Share

  411. AMR RA, Al-Smadi AM, Akasheh RT
    Diabetes knowledge and behaviour: a cross-sectional study of Jordanian adults.
    Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06304.
    >> Share

  412. ELEFTHERIADOU A, Riley D, Zhao SS, Austin P, et al
    Addressing methodological considerations in the assessment of the effect of SGLT2 inhibitors and GLP-1 receptor agonists on diabetic eye complications. Reply to Tsai Y-H, Hemphill NO, Kurth T.
    Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06314.
    >> Share


  413. Correction: 60(th) EASD Annual Meeting of the European Association for the Study of Diabetes, Madrid, Spain, 9-13 September 2024. 'Average glucose and HbA(1c) display a nonlinear and variable relationship: implications for clinical practice'.
    Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06294.
    >> Share

  414. LAN NSR, Hiew J, Ferreira I, Ritter JC, et al
    Increased risk of major adverse cardiovascular events in patients with deep and infected diabetes-related foot ulcers.
    Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06316.
    >> Share

  415. GOTTMANN P, Speckmann T, Stadion M, Chawla P, et al
    Transcriptomic heterogeneity of non-beta islet cells is associated with type 2 diabetes development in mouse models.
    Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06301.
    >> Share

  416. RAO C, Cater DT, Roy S, Xu J, et al
    Beta cell extracellular vesicle PD-L1 as a novel regulator of CD8(+) T cell activity and biomarker during the evolution of type 1 diabetes.
    Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06313.
    >> Share

  417. MA RCW, Tam CHT, Hou Y, Lau ESH, et al
    NT-proBNP improves prediction of cardiorenal complications in type 2 diabetes: the Hong Kong Diabetes Biobank.
    Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06299.
    >> Share

  418. GESUITA R, Eckert AJ, Besancon S, Crimmins NA, et al
    Frequency and clinical characteristics of children and young people with type 2 diabetes at diagnosis from five world regions between 2012 and 2021: data from the SWEET Registry.
    Diabetologia. 2024 Nov 6. doi: 10.1007/s00125-024-06283.
    >> Share

  419. MEIER DT, de Paula Souza J, Donath MY
    Targeting the NLRP3 inflammasome-IL-1beta pathway in type 2 diabetes and obesity.
    Diabetologia. 2024 Nov 4. doi: 10.1007/s00125-024-06306.
    >> Share

  420. GARDEN GL, Fan KS, Paterson M, Shojaee-Moradie F, et al
    Effects of atmospheric pressure change during flight on insulin pump delivery and glycaemic control of pilots with insulin-treated diabetes: an in vitro simulation and a retrospective observational real-world study.
    Diabetologia. 2024 Nov 4. doi: 10.1007/s00125-024-06295.
    >> Share

  421. GLINTBORG D, Christensen LL, Andersen MS
    Transgender healthcare: metabolic outcomes and cardiovascular risk.
    Diabetologia. 2024;67:2393-2403.
    >> Share


  422. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary.
    Diabetologia. 2024;67:2375-2392.
    >> Share

    October 2024
  423. HOSTRUP PE, Schmidt T, Hellsten SB, Gerwig RH, et al
    Effect of fenofibrate on residual beta cell function in adults and adolescents with newly diagnosed type 1 diabetes: a randomised clinical trial.
    Diabetologia. 2024 Oct 30. doi: 10.1007/s00125-024-06290.
    >> Share

  424. TSAI YH, OjiNjideka Hemphill N, Kurth T
    Addressing methodological considerations in the assessment of the effect of SGLT2 inhibitors and GLP-1 receptor agonists on risk of diabetic eye complications.
    Diabetologia. 2024 Oct 30. doi: 10.1007/s00125-024-06300.
    >> Share

  425. VOETS PJGM
    A modified total body water deficit formula for use in diabetes care.
    Diabetologia. 2024 Oct 29. doi: 10.1007/s00125-024-06311.
    >> Share

  426. HANNA SJ, Bonami RH, Corrie B, Westley M, et al
    The Type 1 Diabetes T Cell Receptor and B Cell Receptor Repository in the AIRR Data Commons: a practical guide for access, use and contributions through the Type 1 Diabetes AIRR Consortium.
    Diabetologia. 2024 Oct 29. doi: 10.1007/s00125-024-06298.
    >> Share

  427. SANTOSO C, Wei Y, Ahlqvist E, Tuomi T, et al
    Autoimmune diseases and the risk and prognosis of latent autoimmune diabetes in adults.
    Diabetologia. 2024 Oct 28. doi: 10.1007/s00125-024-06303.
    >> Share

  428. EDSTORP J, Rossides M, Ahlqvist E, Alfredsson L, et al
    Exposure to antibiotics and risk of latent autoimmune diabetes in adults and type 2 diabetes: results from a Swedish case-control study (ESTRID) and the Norwegian HUNT study.
    Diabetologia. 2024 Oct 28. doi: 10.1007/s00125-024-06302.
    >> Share

  429. NATHANSON D, Eeg-Olofsson K, Spelman T, Bulow E, et al
    Intermittently scanned continuous glucose monitoring compared with blood glucose monitoring is associated with lower HbA(1c) and a reduced risk of hospitalisation for diabetes-related complications in adults with type 2 diabetes on insulin therapies.
    Diabetologia. 2024 Oct 26. doi: 10.1007/s00125-024-06289.
    >> Share

  430. MALLONE R
    Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody?positive pre?stage 3 type 1 diabetes.
    Diabetologia. 2024 Oct 24. doi: 10.1007/s00125-024-06296.
    >> Share

  431. CHILUNGA FP, Mkoma GF
    GLP-1 receptor agonists in lean diabetes in racial and ethnic minority groups: closing the treatment gap.
    Diabetologia. 2024 Oct 21. doi: 10.1007/s00125-024-06297.
    >> Share

  432. APAOLAZA PS, Chen YC, Grewal K, Lurz Y, et al
    Quantitative analysis of islet prohormone convertase 1/3 expression in human pancreas donors with diabetes.
    Diabetologia. 2024 Oct 15. doi: 10.1007/s00125-024-06275.
    >> Share

  433. CERIELLO A, Prattichizzo F, Berra C
    Is glycaemic control still central in the hierarchy of priorities in type 2 diabetes management? The way forward is to combine glucose control and the prevention of cardiorenal complications.
    Diabetologia. 2024 Oct 4. doi: 10.1007/s00125-024-06284.
    >> Share

  434. COLE A, Weight N, Mishra S, Grapsa J, et al
    Addressing disparities in the long-term mortality risk in individuals with non-ST segment myocardial infarction (NSTEMI) by diabetes mellitus status: a nationwide cohort study.
    Diabetologia. 2024 Oct 3. doi: 10.1007/s00125-024-06281.
    >> Share

  435. ZHAO LP, Papadopoulos GK, Skyler JS, Pugliese A, et al
    Progression to type 1 diabetes in the DPT-1 and TN07 clinical trials is critically associated with specific residues in HLA-DQA1-B1 heterodimers.
    Diabetologia. 2024 Oct 1. doi: 10.1007/s00125-024-06274.
    >> Share

  436. OKURA T, Ito Y, Anno M, Endo S, et al
    Postprandial fatty acid-binding protein 4 is associated with muscle insulin resistance.
    Diabetologia. 2024;67:2304-2315.
    >> Share

  437. YAMAGUCHI M, Nakao S, Arima M, Little K, et al
    Heterotypic macrophages/microglia differentially contribute to retinal ischaemia and neovascularisation.
    Diabetologia. 2024;67:2329-2345.
    >> Share

  438. WU Y, Yang M, Wu SB, Luo PQ, et al
    Zinc finger BED-type containing 3 promotes hepatic steatosis by interacting with polypyrimidine tract-binding protein 1.
    Diabetologia. 2024;67:2346-2366.
    >> Share

  439. MELLOR J, Kuznetsov D, Heller S, Gall MA, et al
    Estimating risk of consequences following hypoglycaemia exposure using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials.
    Diabetologia. 2024;67:2210-2224.
    >> Share

  440. GRENKO CM, Taylor HJ, Bonnycastle LL, Xue D, et al
    Single-cell transcriptomic profiling of human pancreatic islets reveals genes responsive to glucose exposure over 24 h.
    Diabetologia. 2024;67:2246-2259.
    >> Share

    September 2024
  441. LIU S, Zhu J, Zhong H, Wu C, et al
    Identification of proteins associated with type 2 diabetes risk in diverse racial and ethnic populations.
    Diabetologia. 2024 Sep 30. doi: 10.1007/s00125-024-06277.
    >> Share

  442. SHARMA S, Dong Q, Haid M, Adam J, et al
    Role of human plasma metabolites in prediabetes and type 2 diabetes from the IMI-DIRECT study.
    Diabetologia. 2024 Sep 30. doi: 10.1007/s00125-024-06282.
    >> Share

  443. HOLMAN N, Yelland AC, Young B, Valabhji J, et al
    Mortality rates in people presenting with a new diabetes-related foot ulcer: a cohort study with implications for management.
    Diabetologia. 2024 Sep 27. doi: 10.1007/s00125-024-06262.
    >> Share

  444. HANICK CJ, Peterson CM, Davis BC, Sabate J, et al
    A whole-food, plant-based intensive lifestyle intervention improves glycaemic control and reduces medications in individuals with type 2 diabetes: a randomised controlled trial.
    Diabetologia. 2024 Sep 21. doi: 10.1007/s00125-024-06272.
    >> Share

  445. ELBARBARY NS, Ismail EA, El-Hamamsy MH, Ibrahim MZ, et al
    The DPP-4 inhibitor sitagliptin improves glycaemic control and early-stage diabetic nephropathy in adolescents with type 1 diabetes using the MiniMed 780G advanced hybrid closed-loop system: a randomised controlled trial.
    Diabetologia. 2024 Sep 14. doi: 10.1007/s00125-024-06265.
    >> Share

  446. TSATSARIS G, Rajamand Ekberg N, Fall T, Catrina SB, et al
    Risk factors for Charcot foot development in individuals with diabetes mellitus.
    Diabetologia. 2024 Sep 13. doi: 10.1007/s00125-024-06271.
    >> Share

  447. HEIKKILA TE, Kaiser EK, Lin J, Gill D, et al
    Genetic evidence for efficacy of targeting IL-2, IL-6 and TYK2 signalling in the prevention of type 1 diabetes: a Mendelian randomisation study.
    Diabetologia. 2024 Sep 13. doi: 10.1007/s00125-024-06267.
    >> Share

  448. LAVENS A, De Block C, Oriot P, Crenier L, et al
    Metabolic health in people living with type 1 diabetes in Belgium: a repeated cross-sectional study.
    Diabetologia. 2024 Sep 13. doi: 10.1007/s00125-024-06273.
    >> Share


  449. 60(th) EASD Annual Meeting of the European Association for the Study of Diabetes : Madrid, Spain, 9 - 13 September 2024.
    Diabetologia. 2024 Sep 12. doi: 10.1007/s00125-024-06226.
    >> Share

  450. GALINDO RJ, Soliman D, Chernavvsky D, Rhee CM, et al
    Correction: Diabetes technology in people with diabetes and advanced chronic kidney disease.
    Diabetologia. 2024 Sep 10. doi: 10.1007/s00125-024-06278.
    >> Share

  451. LENZEN S
    Comment on the role of interferons in the pathology of beta cell destruction in type 1 diabetes.
    Diabetologia. 2024 Sep 7. doi: 10.1007/s00125-024-06264.
    >> Share

  452. SORIA-CONTRERAS DC, Wang S, Liu J, Lawn RB, et al
    Lifetime history of gestational diabetes and cognitive function in parous women in midlife.
    Diabetologia. 2024 Sep 6. doi: 10.1007/s00125-024-06270.
    >> Share

  453. WACHOWSKI NA, Pippin JA, Boehm K, Lu S, et al
    Implicating type 2 diabetes effector genes in relevant metabolic cellular models using promoter-focused Capture-C.
    Diabetologia. 2024 Sep 6. doi: 10.1007/s00125-024-06261.
    >> Share

  454. EIZIRIK DL, Zimath PL, Yi X, Roca Rivada A, et al
    Comment on the role of interferons in the pathology of beta cell destruction in type 1 diabetes. Reply to Lenzen S [letter].
    Diabetologia. 2024 Sep 5. doi: 10.1007/s00125-024-06269.
    >> Share

  455. PHILLIP M, Achenbach P, Addala A, Albanese-O'Neill A, et al
    Correction to: Consensus guidance for monitoring individuals with islet autoantibody?positive pre?stage 3 type 1 diabetes.
    Diabetologia. 2024 Sep 4. doi: 10.1007/s00125-024-06266.
    >> Share

  456. THOMSON RL, Brown JD, Oakey H, Palmer K, et al
    Dietary patterns during pregnancy and maternal and birth outcomes in women with type 1 diabetes: the Environmental Determinants of Islet Autoimmunity (ENDIA) study.
    Diabetologia. 2024 Sep 2. doi: 10.1007/s00125-024-06259.
    >> Share

  457. ESSER N, Hogan MF, Templin AT, Akter R, et al
    The islet tissue plasminogen activator/plasmin system is upregulated with human islet amyloid polypeptide aggregation and protects beta cells from aggregation-induced toxicity.
    Diabetologia. 2024;67:1897-1911.
    >> Share

  458. LITHOVIUS V, Lahdenpohja S, Ibrahim H, Saarimaki-Vire J, et al
    Non-invasive quantification of stem cell-derived islet graft size and composition.
    Diabetologia. 2024;67:1912-1929.
    >> Share

  459. WREVEN E, Ruiz de Adana MS, Hardiville S, Gmyr V, et al
    Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans.
    Diabetologia. 2024;67:1877-1896.
    >> Share

  460. MAKINEN S, Sree S, Ala-Nisula T, Kultalahti H, et al
    Activation of the hypoxia-inducible factor pathway by roxadustat improves glucose metabolism in human primary myotubes from men.
    Diabetologia. 2024;67:1943-1954.
    >> Share

    August 2024
  461. DUNNE F, Newman C, Alvarez-Iglesias A, O'Shea P, et al
    Metformin and small for gestational age babies: findings of a randomised placebo-controlled clinical trial of metformin in gestational diabetes (EMERGE).
    Diabetologia. 2024 Aug 31. doi: 10.1007/s00125-024-06252.
    >> Share

  462. MALLIK R, Kar P, Mulder H, Krook A, et al
    The future is here: an overview of technology in diabetes.
    Diabetologia. 2024 Aug 30. doi: 10.1007/s00125-024-06235.
    >> Share

  463. SCIBILIA R, Breslin-Brooker N, Bright C, Dzikiti T, et al
    Global experiences and personal narratives on diabetes technology and access.
    Diabetologia. 2024 Aug 30. doi: 10.1007/s00125-024-06230.
    >> Share

  464. LIN DS, Lee JK, Huang KC, Lin TT, et al
    Effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes in people with diabetes and advanced chronic kidney disease.
    Diabetologia. 2024 Aug 29. doi: 10.1007/s00125-024-06257.
    >> Share

  465. FADINI GP, Longato E, Morieri ML, Bonora E, et al
    Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care.
    Diabetologia. 2024 Aug 23. doi: 10.1007/s00125-024-06251.
    >> Share

  466. TANABE H, Sato M, Miyake A, Shimajiri Y, et al
    Machine learning-based reproducible prediction of type 2 diabetes subtypes.
    Diabetologia. 2024 Aug 21. doi: 10.1007/s00125-024-06248.
    >> Share

  467. KHUNTI K, Zaccardi F, Amod A, Aroda VR, et al
    Glycaemic control is still central in the hierarchy of priorities in type 2 diabetes management.
    Diabetologia. 2024 Aug 19. doi: 10.1007/s00125-024-06254.
    >> Share

  468. LEHNER CT, Schauberger G, Klug SJ
    Reduced type 2 diabetes incidence reflecting end of post?World War II calorie restrictions in Germany. Reply to Nilsson PM, Vaag A [letter].
    Diabetologia. 2024 Aug 17. doi: 10.1007/s00125-024-06255.
    >> Share

  469. PERKINS BA, Turner LV, Riddell MC
    Applying technologies to simplify strategies for exercise in type 1 diabetes.
    Diabetologia. 2024 Aug 15. doi: 10.1007/s00125-024-06229.
    >> Share

  470. NILSSON PM, Vaag A
    Reduced type 2 diabetes incidence reflecting end of post-World War II calorie restrictions in Germany.
    Diabetologia. 2024 Aug 15. doi: 10.1007/s00125-024-06195.
    >> Share

  471. ADEBEKUN J, Nadig A, Saarah P, Asgari S, et al
    Genetic relations between type 1 diabetes, coronary artery disease and leukocyte counts.
    Diabetologia. 2024 Aug 14. doi: 10.1007/s00125-024-06247.
    >> Share

  472. SMITH K, Taylor GS, Peeters W, Walker M, et al
    Elevations in plasma glucagon are associated with reduced insulin clearance after ingestion of a mixed-macronutrient meal in people with and without type 2 diabetes.
    Diabetologia. 2024 Aug 13. doi: 10.1007/s00125-024-06249.
    >> Share

  473. MALTESE G, McAuley SA, Trawley S, Sinclair AJ, et al
    Ageing well with diabetes: the role of technology.
    Diabetologia. 2024 Aug 13. doi: 10.1007/s00125-024-06240.
    >> Share

  474. ELEFTHERIADOU A, Spallone V, Tahrani AA, Alam U, et al
    Cardiovascular autonomic neuropathy in diabetes: an update with a focus on management.
    Diabetologia. 2024 Aug 9. doi: 10.1007/s00125-024-06242.
    >> Share

  475. GALINDO RJ, Soliman D, Chernasvvky D, Rhee CM, et al
    Diabetes technology in people with diabetes and advanced chronic kidney disease.
    Diabetologia. 2024 Aug 8. doi: 10.1007/s00125-024-06244.
    >> Share

  476. YOU L, Ferrat LA, Oram RA, Parikh HM, et al
    Identification of type 1 diabetes risk phenotypes using an outcome-guided clustering analysis.
    Diabetologia. 2024 Aug 6. doi: 10.1007/s00125-024-06246.
    >> Share

  477. HAUKKA JK, Antikainen AA, Valo E, Syreeni A, et al
    Whole-exome and whole-genome sequencing of 1064 individuals with type 1 diabetes reveals novel genes for diabetic kidney disease.
    Diabetologia. 2024 Aug 6. doi: 10.1007/s00125-024-06241.
    >> Share

  478. HURTADO I, Robles C, Peiro S, Garcia-Sempere A, et al
    Association of glucagon-like peptide-1 receptor agonists with suicidal ideation and self-injury in individuals with diabetes and obesity: a propensity-weighted, population-based cohort study.
    Diabetologia. 2024 Aug 6. doi: 10.1007/s00125-024-06243.
    >> Share

  479. RASHID R, Chaudhry D, Evison F, Sharif A, et al
    Mortality risk for kidney transplant candidates with diabetes: a population cohort study.
    Diabetologia. 2024 Aug 6. doi: 10.1007/s00125-024-06245.
    >> Share


  480. Up Front.
    Diabetologia. 2024;67:1453-1454.
    >> Share

  481. VISA M, Berggren PO
    Sex-dependent intra-islet structural rearrangements affecting alpha-to-beta cell interactions lead to adaptive enhancements of Ca(2+) dynamics in prediabetic beta cells.
    Diabetologia. 2024;67:1663-1682.
    >> Share

  482. MELLOR J, Kuznetsov D, Heller S, Gall MA, et al
    Risk factors and prediction of hypoglycaemia using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials.
    Diabetologia. 2024;67:1588-1601.
    >> Share

  483. WINTHER-SORENSEN M, Garcia SL, Bartholdy A, Ottenheijm ME, et al
    Determinants of plasma levels of proglucagon and the metabolic impact of glucagon receptor signalling: a UK Biobank study.
    Diabetologia. 2024;67:1602-1615.
    >> Share

    July 2024
  484. MASALIN S, Klavus A, Rono K, Koistinen HA, et al
    Analysis of early-pregnancy metabolome in early- and late-onset gestational diabetes reveals distinct associations with maternal overweight.
    Diabetologia. 2024 Jul 31. doi: 10.1007/s00125-024-06237.
    >> Share

  485. SOHOLM U, Broadley M, Zaremba N, Divilly P, et al
    The impact of hypoglycaemia on daily functioning among adults with diabetes: a prospective observational study using the Hypo-METRICS app.
    Diabetologia. 2024 Jul 30. doi: 10.1007/s00125-024-06233.
    >> Share

  486. EHRMANN D, Hermanns N, Schmitt A, Klinker L, et al
    Perceived glucose levels matter more than CGM-based data in predicting diabetes distress in type 1 or type 2 diabetes: a precision mental health approach using n-of-1 analyses.
    Diabetologia. 2024 Jul 30. doi: 10.1007/s00125-024-06239.
    >> Share

  487. VERNSTROM L, Gullaksen S, Sorensen SS, Ringgaard S, et al
    Effects of semaglutide, empagliflozin and their combination on renal diffusion-weighted MRI and total kidney volume in patients with type 2 diabetes: a post hoc analysis from a 32 week randomised trial.
    Diabetologia. 2024 Jul 30. doi: 10.1007/s00125-024-06228.
    >> Share

  488. LUNDGAARD AT, Westergaard D, Roder T, Burgdorf KS, et al
    Longitudinal metabolite and protein trajectories prior to diabetes mellitus diagnosis in Danish blood donors: a nested case-control study.
    Diabetologia. 2024 Jul 30. doi: 10.1007/s00125-024-06231.
    >> Share

  489. MOLVEAU J, Myette-Cote E, Tagougui S, Taleb N, et al
    Assessing the influence of insulin type (ultra-rapid vs rapid insulin) and exercise timing on postprandial exercise-induced hypoglycaemia risk in individuals with type 1 diabetes: a randomised controlled trial.
    Diabetologia. 2024 Jul 29. doi: 10.1007/s00125-024-06234.
    >> Share

  490. KONDO A, McGrady M, Nallapothula D, Ali H, et al
    Spatial proteomics of human diabetic kidney disease, from health to class III.
    Diabetologia. 2024 Jul 22. doi: 10.1007/s00125-024-06210.
    >> Share

  491. DONOVAN LE, Bell RC, Feig DS, Lemieux P, et al
    Glycaemic patterns during breastfeeding with postpartum use of closed-loop insulin delivery in women with type 1 diabetes.
    Diabetologia. 2024 Jul 19. doi: 10.1007/s00125-024-06227.
    >> Share

  492. DU S, Sullivan VK, Fang M, Appel LJ, et al
    Ultra-processed food consumption and risk of diabetes: results from a population-based prospective cohort.
    Diabetologia. 2024 Jul 13. doi: 10.1007/s00125-024-06221.
    >> Share

  493. SCULLY KJ, Marks BE, Putman MS
    Advances in diabetes technology to improve the lives of people with cystic fibrosis.
    Diabetologia. 2024 Jul 12. doi: 10.1007/s00125-024-06223.
    >> Share

  494. SCHOELWER MJ, DeBoer MD, Breton MD
    Use of diabetes technology in children.
    Diabetologia. 2024 Jul 12. doi: 10.1007/s00125-024-06218.
    >> Share

  495. WANG W, Bain SC, Bian F, Chen R, et al
    Efficacy and safety of oral semaglutide monotherapy vs placebo in a predominantly Chinese population with type 2 diabetes (PIONEER 11): a double-blind, Phase IIIa, randomised trial.
    Diabetologia. 2024 Jul 10. doi: 10.1007/s00125-024-06142.
    >> Share

  496. JI L, Agesen RM, Bain SC, Fu F, et al
    Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial.
    Diabetologia. 2024 Jul 10. doi: 10.1007/s00125-024-06133.
    >> Share

  497. LUNA-MARCO C, Devos D, Cacace J, Fernandez-Reyes M, et al
    Molecular circadian clock disruption in the leukocytes of individuals with type 2 diabetes and overweight, and its relationship with leukocyte-endothelial interactions.
    Diabetologia. 2024 Jul 10. doi: 10.1007/s00125-024-06219.
    >> Share

  498. BROZZI F, Jacovetti C, Cosentino C, Menoud V, et al
    tRNA-derived fragments in T lymphocyte-beta cell crosstalk and in type 1 diabetes pathogenesis in NOD mice.
    Diabetologia. 2024 Jul 5. doi: 10.1007/s00125-024-06207.
    >> Share

  499. DE WIT DF, Fuhri Snethlage CM, Rampanelli E, Maasen K, et al
    Higher fibre and lower carbohydrate intake are associated with favourable CGM metrics in a cross-sectional cohort of 470 individuals with type 1 diabetes.
    Diabetologia. 2024 Jul 5. doi: 10.1007/s00125-024-06213.
    >> Share

  500. MCLEAN A, Maple-Brown L, Murphy HR
    Technology advances in diabetes pregnancy: right technology, right person, right time.
    Diabetologia. 2024 Jul 5. doi: 10.1007/s00125-024-06216.
    >> Share

  501. DONNELLY LA, McCrimmon RJ, Pearson ER
    Trajectories of BMI before and after diagnosis of type 2 diabetes in a real-world population.
    Diabetologia. 2024 Jul 5. doi: 10.1007/s00125-024-06217.
    >> Share

  502. THABIT H, Schofield J
    Technology in the management of diabetes in hospitalised adults.
    Diabetologia. 2024 Jul 2. doi: 10.1007/s00125-024-06206.
    >> Share


  503. Up Front.
    Diabetologia. 2024;67:1163-1164.
    >> Share

  504. GYLFE E, Tengholm A
    Bo Hellman, 19 June 1930-4 December 2023.
    Diabetologia. 2024;67:1165-1167.
    >> Share

  505. BRAKENRIDGE CJ, Koster A, de Galan BE, Carver A, et al
    Associations of 24 h time-use compositions of sitting, standing, physical activity and sleeping with optimal cardiometabolic risk and glycaemic control: The Maastricht Study.
    Diabetologia. 2024;67:1356-1367.
    >> Share

  506. HTOO PT, Tesfaye H, Schneeweiss S, Wexler DJ, et al
    Effectiveness and safety of empagliflozin: final results from the EMPRISE study.
    Diabetologia. 2024;67:1328-1342.
    >> Share

    June 2024
  507. LIARAKOS AL, Lim JZM, Leelarathna L, Wilmot EG, et al
    The use of technology in type 2 diabetes and prediabetes: a narrative review.
    Diabetologia. 2024 Jun 29. doi: 10.1007/s00125-024-06203.
    >> Share

  508. HASLAM DE, Liang L, Guo K, Martinez-Lozano M, et al
    Correction: Discovery and validation of plasma, saliva and multi-fluid plasma-saliva metabolomic scores predicting insulin resistance and diabetes progression or regression among Puerto Rican adults.
    Diabetologia. 2024 Jun 28. doi: 10.1007/s00125-024-06199.
    >> Share

  509. XIAO Q, Full KM, Rutter MK, Lipworth L, et al
    Long-term trajectories of sleep duration are associated with incident diabetes in middle-to-older-aged Black and White Americans.
    Diabetologia. 2024 Jun 27. doi: 10.1007/s00125-024-06202.
    >> Share

  510. KENNEDY B, Wernroth ML, Batra G, Hammar U, et al
    Major cardiovascular events and death in parents of children with type 1 diabetes: a register-based matched cohort study in Sweden.
    Diabetologia. 2024 Jun 26. doi: 10.1007/s00125-024-06200.
    >> Share

  511. FUHRI SNETHLAGE CM, Balvers M, Ferwerda B, Rampanelli E, et al
    Associations between diabetes-related genetic risk scores and residual beta cell function in type 1 diabetes: the GUTDM1 study.
    Diabetologia. 2024 Jun 26. doi: 10.1007/s00125-024-06204.
    >> Share

  512. BYNDLOSS M, Devkota S, Duca F, Niess JH, et al
    The gut microbiota and diabetes: research, translation, and clinical applications - 2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum.
    Diabetologia. 2024 Jun 24. doi: 10.1007/s00125-024-06198.
    >> Share

  513. PHILLIP M, Achenbach P, Addala A, Albanese-O'Neill A, et al
    Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes.
    Diabetologia. 2024 Jun 24. doi: 10.1007/s00125-024-06205.
    >> Share

  514. D'ALESSIO DA, Kahn SE, Mulder H
    The gut microbiota and diabetes: clarity on an emerging topic and introduction to a new partnership and journal feature.
    Diabetologia. 2024 Jun 24. doi: 10.1007/s00125-024-06208.
    >> Share

  515. UMPIERREZ GE, Davis GM, ElSayed NA, Fadini GP, et al
    Hyperglycaemic crises in adults with diabetes: a consensus report.
    Diabetologia. 2024 Jun 22. doi: 10.1007/s00125-024-06183.
    >> Share

  516. MUTHUKUMAR A, Badawy L, Mangelis A, Vas P, et al
    HbA(1c) variability is independently associated with progression of diabetic kidney disease in an urban multi-ethnic cohort of people with type 1 diabetes.
    Diabetologia. 2024 Jun 20. doi: 10.1007/s00125-024-06197.
    >> Share

  517. GAO L, Ramirez FJ, Cabrera JTO, Varghese MV, et al
    eNAMPT is a novel therapeutic target for mitigation of coronary microvascular disease in type 2 diabetes.
    Diabetologia. 2024 Jun 19. doi: 10.1007/s00125-024-06201.
    >> Share

  518. KOBAYASHI Y, Long J, Johannsen NM, Talamoa R, et al
    Is strength training more effective than aerobic exercise for improving glycaemic control and body composition in people with normal-weight type 2 diabetes? Reply to Pontes?Silva A, Santos?de?Araujo AD, Teixeira BC et al [letter].
    Diabetologia. 2024 Jun 18. doi: 10.1007/s00125-024-06181.
    >> Share

  519. WU M, Yoon CY, Park J, Kim G, et al
    The role of PCSK9 in glomerular lipid accumulation and renal injury in diabetic kidney disease.
    Diabetologia. 2024 Jun 15. doi: 10.1007/s00125-024-06191.
    >> Share

  520. MCNEILLY AD, Gallagher JR, Evans ML, de Galan BE, et al
    Correction: Chronic hyperglycaemia increases the vulnerability of the hippocampus to oxidative damage induced during post-hypoglycaemic hyperglycaemia in a mouse model of chemically induced type 1 diabetes.
    Diabetologia. 2024 Jun 12. doi: 10.1007/s00125-024-06188.
    >> Share

  521. GUDEMANN LM, Young KG, Thomas NJM, Hopkins R, et al
    Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approach.
    Diabetologia. 2024 Jun 5. doi: 10.1007/s00125-024-06190.
    >> Share

  522. VATANEN T, de Beaufort C, Marcovecchio ML, Overbergh L, et al
    Gut microbiome shifts in people with type 1 diabetes are associated with glycaemic control: an INNODIA study.
    Diabetologia. 2024 Jun 4. doi: 10.1007/s00125-024-06192.
    >> Share

    May 2024
  523. ZHANG J, Zhang R, Liu C, Ge X, et al
    Missense mutation of ISL1 (E283D) is associated with the development of type 2 diabetes.
    Diabetologia. 2024 May 31. doi: 10.1007/s00125-024-06186.
    >> Share

  524. SINGH T, Weiss A, Vehik K, Krischer J, et al
    Caesarean section and risk of type 1 diabetes.
    Diabetologia. 2024 May 31. doi: 10.1007/s00125-024-06176.
    >> Share

  525. JEVON D, Cottle L, Hallahan N, Harwood R, et al
    Capillary contact points determine beta cell polarity, control secretion and are disrupted in the db/db mouse model of diabetes.
    Diabetologia. 2024 May 30. doi: 10.1007/s00125-024-06180.
    >> Share

  526. GROEGLER J, Callebaut A, James EA, Delong T, et al
    The insulin secretory granule is a hotspot for autoantigen formation in type 1 diabetes.
    Diabetologia. 2024 May 29. doi: 10.1007/s00125-024-06164.
    >> Share

  527. SALVATORI B, Wegener S, Kotzaeridi G, Herding A, et al
    Identification and validation of gestational diabetes subgroups by data-driven cluster analysis.
    Diabetologia. 2024 May 27. doi: 10.1007/s00125-024-06184.
    >> Share

  528. DE MEULEMEESTER J, Charleer S, Visser MM, De Block C, et al
    The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study.
    Diabetologia. 2024 May 24. doi: 10.1007/s00125-024-06171.
    >> Share

  529. FAGHERAZZI G, Aguayo GA, Zhang L, Hanaire H, et al
    Heterogeneity of glycaemic phenotypes in type 1 diabetes.
    Diabetologia. 2024 May 23. doi: 10.1007/s00125-024-06179.
    >> Share

  530. JUMPERTZ VON SCHWARTZENBERG R, Vazquez Arreola E, Sandforth A, Hanson RL, et al
    Role of weight loss-induced prediabetes remission in the prevention of type 2 diabetes: time to improve diabetes prevention.
    Diabetologia. 2024 May 23. doi: 10.1007/s00125-024-06178.
    >> Share

  531. HANSEN AL, Brons C, Engelhard LM, Andersen MK, et al
    Low birthweight in patients with type 2 diabetes is associated with elevated risk of cardiovascular events and mortality.
    Diabetologia. 2024 May 22. doi: 10.1007/s00125-024-06170.
    >> Share

  532. CARLTON J, Powell PA, Broadley M, de Galan BE, et al
    Development of a new health-related quality of life measure for people with diabetes who experience hypoglycaemia: the Hypo-RESOLVE QoL.
    Diabetologia. 2024 May 22. doi: 10.1007/s00125-024-06182.
    >> Share

  533. PONTES-SILVA A, Santos-de-Araujo AD, Teixeira BC, Carteri RB, et al
    Is strength training more effective than aerobic exercise for improving glycaemic control and body composition in people with normal-weight type 2 diabetes?
    Diabetologia. 2024 May 22. doi: 10.1007/s00125-024-06121.
    >> Share

  534. HASLAM DE, Liang L, Guo K, Martinez-Lozano M, et al
    Discovery and validation of plasma, saliva and multi-fluid plasma-saliva metabolomic scores predicting insulin resistance and diabetes progression or regression among Puerto Rican adults.
    Diabetologia. 2024 May 21. doi: 10.1007/s00125-024-06169.
    >> Share

  535. YUAN S, Leffler D, Lebwohl B, Green PHR, et al
    Coeliac disease and type 2 diabetes risk: a nationwide matched cohort and Mendelian randomisation study.
    Diabetologia. 2024 May 21. doi: 10.1007/s00125-024-06175.
    >> Share

  536. DEL PRATO S, Torbeyns B, Mathieu C
    2024: The year to take European action on diabetes to the next level.
    Diabetologia. 2024 May 18. doi: 10.1007/s00125-024-06166.
    >> Share

  537. SHEU A, White CP, Center JR
    Bone metabolism in diabetes: a clinician's guide to understanding the bone-glucose interplay.
    Diabetologia. 2024 May 18. doi: 10.1007/s00125-024-06172.
    >> Share

  538. IBRAHIM H, Balboa D, Saarimaki-Vire J, Montaser H, et al
    RFX6 haploinsufficiency predisposes to diabetes through impaired beta cell function.
    Diabetologia. 2024 May 14. doi: 10.1007/s00125-024-06163.
    >> Share

  539. BOUGHTON CK, Hovorka R
    The role of automated insulin delivery technology in diabetes.
    Diabetologia. 2024 May 13. doi: 10.1007/s00125-024-06165.
    >> Share

  540. CORPELEIJN WE, de Waal WJ, Schipper HS, Wiegman A, et al
    Should children with type 1 diabetes really receive statin treatment using the same criteria as for children with familial hypercholesterolaemia? Reply to Sanchez?Hernandez and Wagner [letter].
    Diabetologia. 2024 May 13. doi: 10.1007/s00125-024-06174.
    >> Share

  541. GULLAKSEN S, Vernstrom L, Sorensen SS, Ringgaard S, et al
    Correction: Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial.
    Diabetologia. 2024 May 13. doi: 10.1007/s00125-024-06167.
    >> Share

  542. VAN DER SCHUEREN B, Vrijlandt P, Thomson A, Janssen H, et al
    New guideline of the European Medicines Agency (EMA) on the clinical investigation of medicinal products in the treatment and prevention of diabetes mellitus.
    Diabetologia. 2024 May 4. doi: 10.1007/s00125-024-06162.
    >> Share

  543. RAUSCHER FG, Elze T, Francke M, Martinez-Perez ME, et al
    Glucose tolerance and insulin resistance/sensitivity associate with retinal layer characteristics: the LIFE-Adult-Study.
    Diabetologia. 2024;67:928-939.
    >> Share

  544. RUISSEN MM, Steyerberg EW, Huisman SD, de Graaf AA, et al
    Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention. Reply to Pouwer F, Deschenes SS [letter].
    Diabetologia. 2024;67:956-957.
    >> Share

  545. POUWER F, Deschenes S
    Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention.
    Diabetologia. 2024;67:954-955.
    >> Share

  546. IDEVALL-HAGREN O, Incedal Nilsson C, Sanchez G
    Keeping pace: the primary cilium as the conducting baton of the islet.
    Diabetologia. 2024;67:773-782.
    >> Share

    April 2024
  547. KOBAYASHI Y, Long J, Dan S, Johannsen NM, et al
    Correction to: Strength training is more effective than aerobic exercise for improving glycaemic control and body composition in people with normal-weight type 2 diabetes: a randomised controlled trial.
    Diabetologia. 2024 Apr 30. doi: 10.1007/s00125-024-06135.
    >> Share

  548. TREVISAN R, Conti M, Ciardullo S
    Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes.
    Diabetologia. 2024 Apr 29. doi: 10.1007/s00125-024-06158.
    >> Share

  549. CHEN J, Feng Q, Qiao Y, Pan S, et al
    ACSF2 and lysine lactylation contribute to renal tubule injury in diabetes.
    Diabetologia. 2024 Apr 27. doi: 10.1007/s00125-024-06156.
    >> Share

  550. STERNER ISAKSSON S, Imberg H, Hirsch IB, Schwarcz E, et al
    Discordance between mean glucose and time in range in relation to HbA(1c) in individuals with type 1 diabetes: results from the GOLD and SILVER trials.
    Diabetologia. 2024 Apr 26. doi: 10.1007/s00125-024-06151.
    >> Share

  551. TAYLOR GS, Smith K, Scragg J, McDonald TJ, et al
    The metabolome as a diagnostic for maximal aerobic capacity during exercise in type 1 diabetes.
    Diabetologia. 2024 Apr 25. doi: 10.1007/s00125-024-06153.
    >> Share

  552. DENICOLO S, Reinstadler V, Keller F, Thoni S, et al
    Non-adherence to cardiometabolic medication as assessed by LC-MS/MS in urine and its association with kidney and cardiovascular outcomes in type 2 diabetes mellitus.
    Diabetologia. 2024 Apr 22. doi: 10.1007/s00125-024-06149.
    >> Share

  553. KIM JY, Jin SM, Sim KH, Kim BY, et al
    Continuous glucose monitoring with structured education in adults with type 2 diabetes managed by multiple daily insulin injections: a multicentre randomised controlled trial.
    Diabetologia. 2024 Apr 19. doi: 10.1007/s00125-024-06152.
    >> Share

  554. KIM JY, Jin SM, Kang ES, Kwak SH, et al
    Comparison between a tubeless, on-body automated insulin delivery system and a tubeless, on-body sensor-augmented pump in type 1 diabetes: a multicentre randomised controlled trial.
    Diabetologia. 2024 Apr 18. doi: 10.1007/s00125-024-06155.
    >> Share

  555. LI X, Donnelly LA, Slieker RC, Beulens JWJ, et al
    Trajectories of clinical characteristics, complications and treatment choices in data-driven subgroups of type 2 diabetes.
    Diabetologia. 2024 Apr 16. doi: 10.1007/s00125-024-06147.
    >> Share

  556. SACCO S, Foschi M, Ornello R, De Santis F, et al
    Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.
    Diabetologia. 2024 Apr 16. doi: 10.1007/s00125-024-06146.
    >> Share

  557. KARAGIANNIS T, Malandris K, Avgerinos I, Stamati A, et al
    Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials.
    Diabetologia. 2024 Apr 13. doi: 10.1007/s00125-024-06144.
    >> Share

  558. METSALA J, Risnes K, Persson M, Veijola R, et al
    Gestational age at birth and type 1 diabetes in childhood and young adulthood: a nationwide register study in Finland, Norway and Sweden.
    Diabetologia. 2024 Apr 13. doi: 10.1007/s00125-024-06139.
    >> Share

  559. VALABHJI J, Holman N, Collins N, Young RJ, et al
    Can the introduction of a 12-lead ECG help reduce mortality in those presenting with foot ulceration to multidisciplinary diabetic foot clinics? An observational evaluation of a real-world implementation pilot in England.
    Diabetologia. 2024 Apr 8. doi: 10.1007/s00125-024-06134.
    >> Share

  560. ELEFTHERIADOU A, Riley D, Zhao SS, Austin P, et al
    Risk of diabetic retinopathy and diabetic macular oedema with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database.
    Diabetologia. 2024 Apr 8. doi: 10.1007/s00125-024-06132.
    >> Share

  561. SIERRA-SILVESTRE E, Andrade RJ, Colorado LH, Edwards K, et al
    Correction to: Occurrence of corneal sub-epithelial microneuromas and axonal swelling in people with diabetes with and without (painful) diabetic neuropathy.
    Diabetologia. 2024 Apr 5. doi: 10.1007/s00125-024-06138.
    >> Share

  562. LIU B, Xie D, Huang X, Jin S, et al
    Skeletal muscle TET3 promotes insulin resistance through destabilisation of PGC-1alpha.
    Diabetologia. 2024;67:724-737.
    >> Share

  563. XIE C, Iroga P, Bound MJ, Grivell J, et al
    Impact of the timing of metformin administration on glycaemic and glucagon-like peptide-1 responses to intraduodenal glucose infusion in type 2 diabetes: a double-blind, randomised, placebo-controlled, crossover study.
    Diabetologia. 2024 Apr 1. doi: 10.1007/s00125-024-06131.
    >> Share

    March 2024
  564. KORNUM DS, Bertoli D, Kufaishi H, Wegeberg AM, et al
    Transcutaneous vagal nerve stimulation for treating gastrointestinal symptoms in individuals with diabetes: a randomised, double-blind, sham-controlled, multicentre trial.
    Diabetologia. 2024 Mar 28. doi: 10.1007/s00125-024-06129.
    >> Share

  565. VAN DEN BURG EL, Schoonakker MP, van Peet PG, van den Akker-van Marle EM, et al
    Integration of a fasting-mimicking diet programme in primary care for type 2 diabetes reduces the need for medication and improves glycaemic control: a 12-month randomised controlled trial.
    Diabetologia. 2024 Mar 28. doi: 10.1007/s00125-024-06137.
    >> Share

  566. MARCOVECCHIO ML, Hendriks AEJ, Delfin C, Battelino T, et al
    The INNODIA Type 1 Diabetes Natural History Study: a European cohort of newly diagnosed children, adolescents and adults.
    Diabetologia. 2024 Mar 22. doi: 10.1007/s00125-024-06124.
    >> Share

  567. TURNER LV, Marak MC, Gal RL, Calhoun P, et al
    Associations between daily step count classifications and continuous glucose monitoring metrics in adults with type 1 diabetes: analysis of the Type 1 Diabetes Exercise Initiative (T1DEXI) cohort.
    Diabetologia. 2024 Mar 19. doi: 10.1007/s00125-024-06127.
    >> Share

  568. LUND-BLIX NA, Bjerregaard AA, Tapia G, Stordal K, et al
    No association between long-chain n-3 fatty acid intake during pregnancy and risk of type 1 diabetes in offspring in two large Scandinavian pregnancy cohorts.
    Diabetologia. 2024 Mar 19. doi: 10.1007/s00125-024-06125.
    >> Share

  569. GUSTAFSON D, DiStefano PV, Wang XF, Wu R, et al
    Circulating small extracellular vesicles mediate vascular hyperpermeability in diabetes.
    Diabetologia. 2024 Mar 15. doi: 10.1007/s00125-024-06120.
    >> Share

  570. MONTEYNE AJ, Falkenhain K, Whelehan G, Neudorf H, et al
    A ketone monoester drink reduces postprandial blood glucose concentrations in adults with type 2 diabetes: a randomised controlled trial.
    Diabetologia. 2024 Mar 14. doi: 10.1007/s00125-024-06122.
    >> Share

  571. SHE R, Suvitaival T, Andersen HU, Hommel E, et al
    Metabolic effect of adrenaline infusion in people with type 1 diabetes and healthy individuals.
    Diabetologia. 2024 Mar 1. doi: 10.1007/s00125-024-06116.
    >> Share

    February 2024
  572. SU M, Hou Y, Cai S, Li W, et al
    Elevated ITGA1 levels in type 2 diabetes: implications for cardiac function impairment.
    Diabetologia. 2024 Feb 27. doi: 10.1007/s00125-024-06109.
    >> Share

  573. JIN Q, Lau ESH, Luk AO, Tam CHT, et al
    Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank.
    Diabetologia. 2024 Feb 27. doi: 10.1007/s00125-024-06108.
    >> Share

  574. REUTRAKUL S, Park JC, McAnany JJ, Chau FY, et al
    Dysregulated 24 h melatonin secretion associated with intrinsically photosensitive retinal ganglion cell function in diabetic retinopathy: a cross-sectional study.
    Diabetologia. 2024 Feb 27. doi: 10.1007/s00125-024-06118.
    >> Share

  575. TER BRAAKE JG, Fleetwood KJ, Vos RC, Blackbourn L, et al
    Cardiovascular risk management among individuals with type 2 diabetes and severe mental illness: a cohort study.
    Diabetologia. 2024 Feb 26. doi: 10.1007/s00125-024-06111.
    >> Share

  576. COOMANS DE BRACHENE A, Alvelos MI, Szymczak F, Zimath PL, et al
    Interferons are key cytokines acting on pancreatic islets in type 1 diabetes.
    Diabetologia. 2024 Feb 26. doi: 10.1007/s00125-024-06106.
    >> Share

  577. LEHNER CT, Eberl M, Donnachie E, Tanaka LF, et al
    Incidence trend of type 2 diabetes from 2012 to 2021 in Germany: an analysis of health claims data of 11 million statutorily insured people.
    Diabetologia. 2024 Feb 26. doi: 10.1007/s00125-024-06113.
    >> Share

  578. SANCHEZ-HERNANDEZ RM, Wagner AM
    Should children with type 1 diabetes really receive statin treatment using the same criteria as for children with familial hypercholesterolaemia?
    Diabetologia. 2024 Feb 26. doi: 10.1007/s00125-024-06115.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016